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ABSTRACT
Transgenic and knockout mouse models of disease and gene function have 
revolutionised the field of biomedical research and the targeted mutations of genes 
expressed in the brain are revealing the mechanisms underlying normal behaviour and 
behavioural abnormalities which has led to the development of behavioural 
neuroscience. However, it is also clear that the phenomena know as “redundancy,') can 
limit the effectiveness of traditional knockout models by die effects of compensatory 
mechanisms. This thesis utilises transgenic and knockout mouse models to explore the 
role of the tachykinins in the pathogenesis of anxiety, depression and epilepsy 
focusing on the TAC1 gene products and their functionality via the TACR1 (NK1) 
receptor.
The generation of a novel double knockout line via the cross breeding of single 
knockout models relevant for the tachykinin signalling pathways circumnavigates the 
problems associated with redundancy and also reveals that this phenomena is 
contributing to the data generated using the single knockouts. The use of these animals 
in a variety of experimental models to compare their function with the original 
“parental” knockouts and their corresponding wildtype controls reveals novel models 
for the action of the tachykinins in epilepsy and suggests a correlation with serotonin 
levels with an ultimate effect on the behavioural responses observed.
Interestingly, during analysis and experimental design it became clear that the sex of 
the animal was a parameter that had a statistically significant effect on the results. This 
was further investigated and the data alludes to a sex dependent level of control of the 
tachykinins and their involvement in the aetiology of epilepsy. Models generated as
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part of this thesis were also analysed and utilised in virus infection experiments were 
it became apparent that the genetic background of the mouse model is also a 
determining parameter.
The data presented in this thesis clearly demonstrates that the double knockout of both 
the Tael gene and the high affinity receptor Tacrl has a distinct behavioural response 
that is unique to either individual knockout for certain neurological disorders but 
displays a phenotype that is consistent with that of the single knockouts for other 
disorders of neurological origin.
This demonstrates the complex regulatory mechanisms involved in the mood 
disorders and epilepsy and also supports a differential functional response of the 
Tacrl mediate by various tachykinin activation of the receptor.
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Chapter 1. General introduction.
1: Introduction
1.1 Overview
The study described in the following thesis has generated and utilised mouse models 
to examine and explore the role of the tachykinin genes involved in the mood 
disorders and epilepsy in-vivo. In addition, an important part of this thesis was to 
explore the transcription factors implicated in the neurological disorder that is epilepsy 
and its association with the mood disorders suggesting a regulatory link of the 
tachykinins on serotonin levels.
Genes of particular interest in the mood disorders and epilepsy are explored including 
the TAC1 gene (originally known as Preprotachykinin-A, PPTA) which encodes 
several tachykinins including Substance P (SP) and Neurokinin A (NKA) and the 
TACR1 gene (also known as Neurokinin 1 gene, NK1) which is SP’s preferred 
receptor in the central nervous system (CNS), as well as the SLC6A4 gene (producing 
the Serotonin Transporter protein, 5HTT or SERT). Recently, another tachykinin 
peptide produced in non neuronal cells and tenned hemokinin (encoded by the TAC4 
gene) has extended the tachykinin family. Hemokinin also shows a preference for the 
receptor TACR1 and the importance of this is explored and discussed.
Both the human and rodent genes and gene products are studied, compared and 
contrasted during the course of the thesis. The objective, to contribute to the 
knowledge of the regulation and role these genes play in the mood disorders and 
epilepsy, is discussed and summarised during the course of the thesis.
16
1.2 Human verses mouse genome
Humans and mice diverged an estimated 75 million years ago. Although this has 
meant that evolution has changed their comparative genomes via substitution, 
deletion and insertion of nucleotides it has also resulted in regions that can be 
recognised as being functionally important due to the high level of conservation of 
the genetic sequences. Biologically, humans and mice are closely related and have 
almost all the same organs. In fact, mice are at least as closely related biologically to 
humans as any of the familiar agricultural and domestic mammalian species. Only 
primates are closer evolutionarily. The human genome mapping project (HGMP) 
completed a working draft of the human genome in 2001 with a complete sequence 
in 2003. Recognising the importance of mice in research the sequencing of the 
mouse genome was quickly completed and published using the most widely used 
inbred strain, the C57BL/6J mouse in 2002 by the Mouse Genome Sequencing 
Consortium (only females were used due to the highly repetitive regions in the Y 
chromosome, 99.9% sequence homology). Comparison between the genomes 
provided the following key points (taken from nature article “Initial sequencing and 
comparative analysis of the mouse genome”; Waterston et al, 2002):-
• The mouse genome is 14% smaller than the humans (2.5 GB compared to 2.9
GB).
• More than 90% of the human and mouse genomes can be partitioned into
corresponding regions of conserved synteny showing that the gene order
from our common shared ancestor has been conserved in both species.
• On a nucleotide level, approximately 40% of the human genome can be
directly aligned to the mouse genome.
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• Comparison of the genomes found a level of conservation that cannot be
explained by protein-coding sequencing alone, indicating that a larger 
proportion of conservation has occurred in regulatory regions, non-protein 
coding genes and chromosomal structural elements.
• The level of the genomes that is protein-coding genes is comparable with an
estimated 30,000 protein-coding genes in each species.
The mouse genome consortium evaluated the conserved synteny between the human 
and mouse genome across the species chromosomes (figure 1.1) and provided 
knowledge with regards some of the problems that can be encountered when trying 
to generate humanised mouse models because genes that are conserved between the 
species have been subjected to translocations, chromosomal breaks and 
chromosomal rearrangements. Thus, even if the protein-coding regions of an 
individual gene are conserved between the two species the nearby genes and 
regulatory regions may not be and this must be considered when making mouse 
models as it may not be the final translated protein that differs between the species 
but rather its temporal and spatial expression pattern which will affect its ultimate 
functionality. The similarity of the protein-coding regions across the two species can 
also lead to problems during the analysis of the model and this must also be 
considered when generating mouse models. Both of these points will be discussed 
further in the relevant sections of this thesis.
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Figure 1.1 reproduced from mouse genome sequencing consortium. Each colour 
corresponds to a particular human chromosome. The bottom boxes indicated a 
colour for each of the human chromosomes. This colour guide is used to illustrate 
the corresponding position of the genes found on human chromosomes with regards 
their position on the mouse chromosomes. For example, the genes on human 
chromosome 1 represented in grey are present on mouse chromosomes but 
distributed across mouse chromosomes 1, 3 and 4. In contrast the human and mouse 
X chromosome has almost perfect synteny.
The fact that protein-coding coding sequences and an even higher proportion of non­
protein coding sequences have been conserved across the two species explains why 
the mouse has been such a valuable tool in in-vivo research even before the use of 
recombinant DNA technology. Like humans and many other mammals, mice 
naturally develop diseases that affect physiological systems, including cancer.
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atherosclerosis, hypertension, diabetes, osteoporosis and glaucoma. Early work done 
on the first laboratory strains of mice has laid the foundation for current knowledge 
on cancer and tumour growth and led to the discovery and elucidation of the role of 
the TP53 gene that expresses the tumour suppressor p53 as well as numerous other 
oncogenes (review, Goldstein et al, 2011), The discovery and use of recombinant 
DNA technology has helped with diseases that afflict humans but are not usually 
found within the murine population, such as cystic fibrosis and Alzheimer's disease, 
as they can be induced by manipulating the mouse genome and environment. There 
are also behavioural test analogues for the mood disorders in humans that can be 
applied to mice which have been particularly useful in mouse models for studying 
behaviour disorders and antidepressant drugs and these have been applied and used 
within this thesis. It is worth noting, however, that the use of mouse models does 
have limitations and drawbacks such as, for example, the absence of many of the 
human polymorphic domains associated with the progression of neurological 
disorders. In particular they lack the VNTR region (variable number tandem repeats) 
found in the SLC6A4 gene (Holmes et al, 2003) and this will also be considered and 
discussed further in the introduction of this thesis.
1.3 Knockout mouse lines
The use of recombinant DNA techniques and embryonic stem cell technology in the 
1980s resulted in knockout mouse models for human diseases via homologous 
recombination in embryonic stem cells of an artificial targeting vector and the 
endogenous gene of interest (Crawley, 2008; Muller, 1999, reviewed in Brandon et 
al, 1995). Generally, knockout defines a mouse model that has had an endogenous
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gene disrupted or partially deleted. It is specifically defined as a targeted mutation 
(tm) in the nomenclature and knowledge of the gene sequence to be disrupted must 
be known in order to construct the targeting vector. In the vast majority of cases 
knockouts have a mutation introduced into an exon of the genes reading frame that 
is critical for the expression of the gene product of interest. The mutation usually 
results in deletion of a portion of DNA but can also shift the reading frame for the 
DNA resulting in incorrect reading of the triplet base pair codes compromising the 
gene product. It is often thought that the resultant knockout will have a phenotype 
that has a complete absence of the protein of interest. While this is sometimes the 
case it is also possible to have a truncated form of the gene product or an inactivated 
form of the gene product due to incorrect translation or incorrect folding of the 
protein post translational. The targeting vector that achieves this disruption often has 
the neomycin resistance gene (Neo) added as a selectable marker along with 
sequences homologous to the gene of interest for the recombination event (Figure 
1.2).
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Endogenous Allele
Figure 1.2. A typical targeting vector reproduced from transgenic mouse core 
facility. A targeting vector contains three basic units consisting of A) a fragment of 
DNA homologous to the 5' end of the gene (the 5' arm), B) a selectable gene marker, 
most commonly the neomycin resistance gene, and C) a fragment of DNA 
homologous to the 3' end of the gene (the 3' arm). In general, the targeting vector is 
designed such that some portion of the endogenous gene is replaced by the 
neomycin cassette in the targeted allele. Deletion of the initial coding exon can 
ensure that a truncated protein is not produced.
1.4 TAC1 and TACR 1
Substance P (SP) was discovered in 1931 (Von Euler and Gaddum, 1931) and has 
been extensively studied along with the ever growing numbers of identified 
neuropeptides. Neuropeptides are small proteins that serve neurotransmitter-like 
roles in the nervous system. Similar signalling peptides (growth factors and 
cytokines) are considered to be a distinct class even though they may have some 
overlapping functions. SP has been of particular interest because it is implicated in a 
multitude of functions including pain perception, mood, fear and anxiety, 
inflammation, blood pressure, appetite and digestion (review, MacKenzie and
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Quinn, 2004). It is SPs actions in the regulation of mood and in particular the control 
of fear and anxiety that this thesis has focused on and the initiation of its functions 
via its preferred receptor in CNS, TACR1 (previously known as Neurokinin-1 
receptor).
SP is coded for by the TAC1 gene which is sometimes referred to as the PPTA gene. 
The TAC1 gene encodes four products of the tachykinin peptide family, SP and 
neurokinin A (NKA, previously known as substance K), as well as related peptides, 
neuropeptide K and neuropeptide gamma (neuropeptide-y) (Bannon et al, 1992).
The human TAC1 gene is 8kb long located on chromosome 7 (7q21-q22) and 
consists of 7 exons which give rise to 4 alternatively spliced mRNA transcripts 
(prepropeptides) which are termed a, (3, y, and 8 (Figure 1.3). Each prepropeptide 
differs in its exon composition: the (3 utilises all 7 exons, the a lacks exon 6, the y 
lacks exon 4 and the 8 lacks both exons 4 and 6. Polypeptides produced from these 
splice variants allow cells to produce SP encoded from exon 3 present in all splice 
variants. NKA is encoded from exon 6 and is therefore only produced from P and y 
mRNAs. NPK and NPy are N-terminal extended forms of NKA and are produced 
from p and y PPT-A mRNA respectively. Alternative splicing of these 4 mRNA 
transcripts and post translation modification of the precursor polypeptide results in 
the production of the active neuropeptides (Satake et al, 2004).
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PPT-A/TAC 1 gene
N P y
N P K
1 3 4 5 6 7
N K A
Protein sequence
SP: RPKPQQFFGLM-NH2 
N K A: HKTDSFVGLM- N H 2
NPK: DADSIEKQVALLKALYGHGQISHKRHK 
TDSFVGLM - N H 2
NPy: DAHHGQISHHKRHKTDSFVGLM-NH2
Figure 1.3: Schematic representation of biosynthesis of tachykinin products from 
humanTACl. The TAC1 gene encodes 4 splice variants a, (3, 8, y which have different 
combinations of exons. Exon 3 is required for the production of SP, exon 6 is 
required to encode NKA. NPK requires exons 5 and 6 and NPy requires exons 6 and 
7. Transcription and translation products are shown.
In contrast, the mouse Tael gene is located on chromosome 6 (chr6:7505071- 
7512973bp) and is also alternatively spliced and undergoes post-translational 
processing to produce SP, NKA, NPK and NPy. The related tachykinin peptide 
neurokinin B (NKB) is coded by the TAC3 gene in humans and the Tac2 gene in mice.
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TACR1 (often referred to as NK1 receptor) is expressed by a single-copy TACR1 
gene found on chromosome 2 in humans (2p 13.1-pi2), consists of 407 amino acid 
residues and has a molecular weight of 58u. SP is selective for the TACR1 receptor 
and has a high affinity for it, the affinity of NKA, for comparison, is 100 fold lower 
(Gerard et al, 1991). The order of affinity for the TACR1 is SP>NKA>NKB. NKA 
has a preference for TACR2. The TACR1 gene belongs to a gene family of 
tachykinin receptors that are characterized by their interactions with G proteins and 
contain seven hydrophobic transmembrane regions and also includes NK2 and NK3 
receptors. TACR1 is localized in high concentrations in the CNS (particularly the 
striatum, amygdala and some thalamic nuclei) and peripheral tissue where they 
mediate their control of physiological functions including stress reactions, mood, 
immune modulation, excitatory neurotransmission and neurogenic inflammation. 
However, TACR1 is also found in epithelium and many other cells.
The mouse Tacrl is coded by the Tacrl gene located on chromosome 6 
(chr6:82352469-82510093bp) and is also a single-copy Tacrl gene that is also 
expressed and localised in high concentrations in the CNS and peripheral tissues. 
Further human and mouse expression patterns will be discussed in more detail in the 
relevant chapters of this thesis.
As mentioned previously SP belongs to a family of neuropeptides known as the 
tachykinins found in the CNS as well as the PNS and have neurotransmitter like 
properties. They share the same hydrophobic C-tenninal region with the amino acid 
sequence Phe-X-Gly-Leu-Met-NH2 where X represents a hydrophobic residue that 
is either aromatic or aliphatic (ringed or non-ringed carbon atoms). They can initiate
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neurotransmission by themselves or synergistically with classic neurotransmitters 
such as the monoamines, acetylcholine and glutamate at the nerve terminals of 
neurons (Sergeyev et al3 1999). However, the production, synaptic storage and 
regulation of neuropeptides is distinct from the classic neurotransmitters which are 
synthesised in the presynaptic terminal and stored in small synaptic vesicles that are 
constructed in the terminal region. In contrast, the tachykinins are expressed by 
endogenous genes and their complexity and numbers are obtained via 
transcriptional, translational and posttranslational modification in the cell body and 
axon regions. They are then processed and packaged into large dense core vesicles 
that are assembled in the Golgi apparatus and fransported to the synapse. The 
tachykinins and classic neurofransmitters do share a common feature however, and 
that is the co-localisation of their vesicles at the nerve terminals of neuronal cell 
types. In fact, this co-localisation of vesicle storage is a defining feature of all the 
neuropeptides (figure 1.4).
SP is released through the depolarising action of calcium dependent mechanisms 
and stimulates the membrane bound TACR1 to generate second messengers that can 
trigger a wide range of effecter mechanisms that regulate cellular excitability and 
function.
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Figure 1.4. Reproduced from the NCB1 website. Co-localisation of classic 
neurotransmitters in small clear core vesicles near the synaptic terminal along with
the large dense core vesicles containing the neuropeptides that are transported to
the membrane for release on stimulation.
Originally, it was thought that SP and its preferred receptor, TACR1, existed 
primarily within the neuronal synapse, this was the assumption for many 
neuropeptides and their receptors. With research it has been discovered that this is 
clearly not the case especially with regards the TACR1 which has been found all 
over the cell body of neurons as well as in the brainstem, on the surface of vascular
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endothelial cells, in muscle, gastrointestinal tracts, pulmonary tissue, thyroid gland 
and immune cells.
SP and TACR1 have been implicated in a wide range of functions including pain 
perception and neurogenic inflammation. Since inflammation and pain is involved in 
the vast majority of disease states and tissue injury it is no surprise that SP has been 
implicated in the pathophysiology of many abnormal states ranging from stress, 
anxiety, infection and the immune response, mood, fibromyalgia, depression and 
epileptic seizures. Once an inflammatory state is induced the levels of SP and 
TACR1 increase and SP is able to diffuse even deeper across more layers of tissue 
and bind receptors in the surrounding neurons creating a cascade effect (Brown et al, 
1995). As a result both SP and TACR1 are often the targets for preclinical trials of 
antagonists for a variety of conditions.
For the purposes of this thesis we are particularly interested in the role SP and 
TACR1 plays in the CNS with regards anxiety, depression and epilepsy and this will 
be discussed and documented further in the chapters.
SP and TACR1 are particularly prevalent in the areas associated with the control of 
fear and anxiety such as the amygdala, hypothalamus and periaqueductal gray 
(Davidson et al 2006, Riberiro-da-Silva et al 2000) and also in the hippocampus 
which is the main area of the brain associated with epileptic seizure activity (figure 
1.5).
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Figure 1.5. Reproduced and modified from mindblog. The periaqueductal gray 
(PAG) can only be seen through sections of the brain but is located in close 
proximity to the amygdala and hypothalamus.
As a result many TACR1 antagonists have been deployed and used in animal 
research and have been shown to display anxiolytic and antidepressant like effects 
(Vendruscolo et al 2003, Rodgers et al 2004). Support for the involvement of the 
tachykinin system in the pathophysiology of mood disorders was further 
demonstrated by the use of the TACR1 receptor antagonist, MK869, in a placebo- 
controlled clinical trial (Czeh et al 2006, Kramer et al 1998).
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1.5.1 Tad and Tacrl knockout mouse models
The research into SP function and regulation via its preferred receptor TACR1 has 
been aided by the creation of genetically altered mice that have had their Tael and 
Tacrl genes disrupted resulting in strains of “knockout” mice that lack the gene 
products SP and Tacrl respectively.
There are currently two knockout models for Tad gene. The first, and the one used 
in this thesis is the “Zimmer” model and is discussed in more depth further on. The 
correct nomenclature for this knockout is B6.Cg-Thc7 tmlnmh/]^ por this strain a 
targeting vector containing the neomycin and thymidine kinase resistance genes was 
used to disrupt the Tad gene by replacing parts of exons 2 and 3 using MP12 
embryonic stem cells for homologous recombination. The neomycin gene allows for 
positive selection of recombinant embryonic stem cells and the thymidine kinase 
resistance gene is used to check for non-specific recombination events. Zimmer then 
backcrossed his mice for 10 generations onto C57BL/6J mice before inbreeding to 
generate a null model that does not produce any detectable levels of SP or NKA but 
does express the other gene product peptides. It is not clear from the literature but 
the partial removal of exon 3 may produce a detectable but possibly inactive or 
truncated form of NPK (neuropeptide K).
The second is the “Basbaum” model. Correct nomenclature is R6.Cg-TacltmlBbmH. 
For this strain a targeting vector containing the neomycin resistance and thymidine 
kinase genes was used to disrupt the Tad gene by replacing coding exon 3 and 
deleting the NKA coding region in exon 6 using CB1-4 embryonic stem cells for 
homologous recombination. Basbaum then backcrossed the mice for 7 generations 
onto C57BL/6J before sending them to the Jax labs who then backcrossed them for
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another 5 generations onto C57BL/6J before inbreeding the homozygous null line 
which is currently up to generation 6 of filial inbreeding (sister x brother mating) as 
of January 2011. This null model also does not produce any SP or NKA but may 
have a very different flanking sequence to the B6.Cg-7hc7 lmhumhj] model. The 
importance of the flanking gene sequence is discussed further in the relevant 
chapters of this thesis.
There are currently two knockout models for the Tacrl gene. Since the Tacrl gene 
has no alternative splicing and therefore only produces Tacrl, different models are 
less of an issue because they will all essentially be null for the Tacrl. What is a big 
issue for these (and all mouse models) is the background strain they are on and the 
two that are available are on different backgrounds and have produced very different 
and contrasting results which demonstrates the importance of background (Bilkei- 
Gorzo et al paper in 2002).
The first Tacrl null (B 6. Cg- Tacrl tin lud/J), and the one used in this thesis, is known as 
the “Hunt” model and is discussed in more detail further on in this thesis (Carmen 
De Felipe et al, 1998). The recombination event deletes exon 1 which ensures that 
there will be no truncated product produced.
The second Tacrl null (not used in this thesis) is documented in Santarelli et al, 
2001 and uses a PGK-neo targeting cassette which also replaces exon 1 resulting in 
the deletion of the first two transmembrane domains of the Tacrl generating a 
mouse model null for the receptor as confirmed by in situ hybridisation and 
immunocytochemistry. In this model, however, they used only 129/Sv mice 
generating a pure inbred background but this strategy does have its drawbacks which 
will be discussed further on in this chapter.
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The two “knockout” mice strains used in this thesis (B6.Cg-Tacrltmhtcil] and B6.Cg- 
Tacl ",,7'nm/7j models) have been extensively studied in behavioural testing and have 
been found to have common phenotypes including lowered anxiety levels, reduced 
fear responses, higher pain thresholds and lowered inflammatory x’esponse (Bilkei- 
Gorzo et al, 2002; Zimmer et al 1998). These models were also subjected to various 
behavioural testing as part of this thesis and the relevance of the tests used as well as 
the results from this thesis and other peer reviewed papers will be compared and 
contrasted in the relevant chapters of this thesis.
1.5.2 Tad knockout mouse model used in this thesis
Since it has already been stated that the background strain of mouse used for a 
knockout line makes a difference further details on the generation and breeding of 
knockout mice used in this thesis are now given. The first was the Tael knockout 
(B6.Cg-7hc7 tminimhi^ generated by selective deletion of the SP coding region by 
homologous recombination of a targeting vector with parts of exons 2 and 3 in ES 
cell lines which are derived from the 129SV/J strain (see figure 1.6 for targeted 
deletion).
32
B7 - PPT fnKNA 
ft • PPT mRNA
a • PPT mRNA [I[2lfil4j5i :;r
SPfSK 
SP ♦ SK
SP
Nsi I Kpn
t
1 2 3 4 5
i n—m----------r ----- 1-- T -ii
H U N
PU +P2 P4 + *P51 1 i 1 1 1 1 1
I
1 2 tTA neof 4 5
I
rr--------r- i
 6
1
HSV-Tk
r
K N N
■■Lj__ :__ a
Tad129 
Tad 057
targeting construct
Tad ITAa^o
1 2 tTA neof 4 5
11 L i I I«
illillli
oo oo oooo
JO <tJ .<0 jW it* <T5 , tp
probe
liy iillli
oyoooooooo
controi
Figure 1.6 Reproduced from Zimmer et al, 1998 to show targeted deletion on 
endogenous mouse PPT-A gene for generation of knockout mice. Targeted 
mutagenesis of the Tael gene. (A), shows the prepropeptide mRNA transcripts and 
also the different cDNA from the mouse strains 129SV/J (Tacl129) and the C57BL/6J 
(TaclC57), the targeting construct used with the neomycin resistance gene, and the 
recombinant locus (Tacl'TAneo). (B) Shows Southern blot analysis to identify 
recombinant ES cell. (C) Shows PCR genotyping of offspring from TacltTAneo/cy> * 
TacltTAneo/c57 matings (D), Zimmer used probes to differentiate between the genotypes 
of offspring from Tacl129 a 7 x Tacl129C'7 matings by PCR amplification with primers 
P4 and P5, and subsequent digestion with Hpall. Note that Hpall cuts only the PCR 
fragment derived from the 129 allele, but not the C57BL/6 allele. tTA (tetracycline 
transactivator protein).
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In the original paper problems associated with the allele distribution within the 
offspring of his FI progeny from the germ-line chimera to C57BL/6J matings was 
recognised (Zimmer et al, 1998). To address this issue the hpall polymorphism was 
used as a unique DNA marker sequence as it is only present in intron 6 of the 
129SV/J mice so it is possible to distinguish the wildtype alleles donated by either 
the 129 or C57BL/6J line. Zimmer then interbred his FI progeny together to produce 
two lines, a knockout line for the Tael gene and a suitable wildtype control line 
whose Tael locus is derived only from 129SV/J mice. However, whilst they are 
suitable controls and knockouts for the Tael locus they are now on a mixed 
background of 129 x C57BL/6 strains so they are a heterogeneous population with 
increased variability. Never the less Zimmer has effectively addressed the control 
animal for the area of modification he is looking at, in other words comparing the 
129 Tael locus intact with the 129 Tael locus disrupted by the targeting vector.
The B6.Cg-7hc7 lmlnmhj^ mjce were then used for behavioural testing. For certain 
aspects of behavioural testing the 129SV line of laboratory mice makes a poor 
model due to a lack of communication between the two cerebral hemispheres caused 
by congenital agenesis of the coipus callosum (Magara et al, 1999; Trillat et al, 
1998). The coipus callosum is a large bundle of axons that interconnect neurons in 
the two hemispheres. The developmental mechanisms causing the defects of the 
corpus callosum are not completely understood but research indicates the problem is 
in the substrates of axon guidance at the midline structure and the BALB/c inbred 
stain also suffers from this phenomenon (Ozaki and Wahlsten, 1993). In a paper by 
Gardier and Bourin, 2001, demonstrated the problem of background strain is noted 
as an issue particularly when testing knockout mice as models of depression or using 
them to test the efficacy of antidepressants. Unfortunately this is quite a common
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problem as many existing models are from a 129 lineage as discussed earlier with 
regards availability of ES cells lines.
To address the problem of background Zimmer went on to backcross his Tael 
knockout mice for 10 consecutive generations to a C57BL/6J strain. In a paper in 
2002 he subjected the mice to various behavioural testing to evaluate their responses 
with confidence (Bilkei-Gorzo et al, 2002). The B6.Cg-7be7 tml,umh/] knockout on 
the C57BL/6J background is the one that was used throughout this thesis therefore 
the problem of 129SV lineage will be effectively dismissed but the DNA sequences 
flanking the Tael open reading frame may still be an issue with regards this strain 
and this will be discussed in chapter 3 of this thesis.
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1,5.3 Tacrl knockout mouse model used in this thesis
The other knockout used in this thesis was the B6.Cg-Tacrltmiudl] line (Carmen De 
Felipe et al, 1998). Here, the ES cell line used was the HM1 line which is derived 
from the 129P2/01aHsd line (Jax labs). The authors, however, quote a 129/Sv 
parentage. The incorrect use of mouse nomenclature is a common problem in many 
publications and has ramifications with regards replication of x'esults. Whilst the 
problem of defective corpus callosum is not reported as frequently with the 
129P2/01aHsd lineage of 129 mice they are still related to the Sv substrain and should 
still be considered a poor model background strain for behavioural studies and testing 
of antidepressant drugs. In the original work there was no provision made to 
distinguish between the wildtype allele originating from the 129 line and the one 
originating from the C57BL/6 line used to produce the FI generation. Mice 
heterozygous for the disrupted allele were interbred to produce the null Tacrl mice 
and presumably the wildtype controls that were used to confirm successful disruption 
of the Tacrl gene via auto radiographic mapping of the SP binding sites in the 
forebrain and spinal cord (see figure 1.7).
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Figure 1.7 Reproduced from Carmen De Felipe et al paper to show targeting 
construct in the B6.Cg-Tacrltmiud/J mice. A, Drawing of the region of the wild-type
NK-1 locus containing exon 1 and the recombination event with the targeting vector. 
B, Southern blot analysis of offspring from an NK1+A intercross to detect nulls. 
Homozygous (12 kb), heterozygous (12 kb and 8 kb) and wild-type (8 kb) mice were 
generated at a ratio of 1:2:1. c, d, Auto radiographic mapping of SP binding sites in 
fore bra in (c) and spinal cord (d) sections of NK1'/' and NK1+/+ mice.
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These two lines of mice (nulls versus controls) were then subjected to various 
nociceptive and behavioural testing. Whilst the assessment of the null Tacrl locus is 
homozygous (both alleles disrupted) and 129 in origin, the testing and assessment of 
the wildtype locus could potentially be very mixed due to flanking sequences 
originating from both 129 and C57BL/6J (BL6) background strains. In the F2 and F3 
generations there is the statistically likelihood that controls with the following 
wildtype Tacrl locus origins will have been used; 129/129; BL6/BL6 and 129/BL6, in 
other words not just variation on the background strain but also variation at the locus 
of interest. As with the B6.Cg-7bci tm}nmhH knockout line this variation and lack of 
suitable controls was addressed with the backcrossing of the R6.Cg-Tacrltmiuci!l mice 
for 10 consecutive generations onto the C57BL/6J background and it was this line that 
we received and used as part of this thesis. For that reason we will again dismiss the 
problem of the 129P2/01aHsd lineage but consider the flanking gene issue in our 
discussion of the results from experiments using this line.
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7.6 Role of serotonin (5HT) in behaviour disorders
Since the data presented in this thesis focuses on the role of the tachykinins in anxiety, 
depression and epilepsy it is appropriate to mention and give an overview of the 
neurotransmitter serotonin (5HT) as it is often the monoamine that is the focus for all 
the mood disorders.
Serotonin is one of the most extensively studied neurotransmitters and yet its role in 
the brain remains poorly understood. This is no doubt in part due to the fact that it 
seems to be involved in virtually everything from mood to sleep, human behaviour 
and mental disorders, circadian rhymes, smooth muscle contractions and recently 
implicated in epilepsy as well. There is also evidence to suggest that serotonin (also 
known as 5-hydroxytryptamine, 5HT) acts as maternal “morphogen” in conjunction 
with the foetal serotonin transporter protein (SLC6A4 also known as 5HTT and 
SERT) to direct and “orchestrate” the complex neuronal arrangement of not only the 
central nervous system (CNS) but also the enteric nervous system (ENS), (Zhou et al, 
2000). It is also one of the most ancient neurotransmitters involved in life on earth 
with its functional use dating back in evolutionary terms to jellyfish with a 
diversification timeline of 800 million years ago. 5HT interacts with a multitude of 
genes and has many regulators but without a doubt the serotonin transporter protein 
(SLC6A4, SERT) is one of the most critical regulators of serotonin through removal 
of extracellular 5HT, to fine-tune serotonin signalling (figure 1.8).
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Figure 1.8 Image reproduced from NIDA website. Serotonin is stored in small 
vesicles near the synaptic cleft of a neuron unlike the tachykinins that are stored in 
large dense core vesicles of the neuron cell body. It acts as a chemical messenger 
across the cleft to signal on the post synaptic neuron via various receptors. In this 
picture the serotonin transporter protein (SLC6A4,) is illustrated on the membrane of 
the pre-synaptic neuron actively taking up the serotonin and in so doing it regulates 
the amount of serotonin signalling across the cleft along with various other 
mechanisms including a serotonin inhibitory feedback loop.
Since the neurotransmitter serotonin (5HT), and its main regulator the SLC6A4 
protein, are historically well documented to be pivotal in the control of mood and 
behavioural disorders a lot of research has focused on a regulatory link between 5HT, 
SLC6A4, SP and its preferred receptor TACR1. This is confirmed by a number ot
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papers that show the presence of the TACR1 receptor on 5HT neurons of the Dorsal 
raphe nucleus, a major source of serotonergic input to the forebrain (Lacoste et al, 
2006), and further substantiated by the findings that disruption and drug blockage of 
the TACR1 receptor reduces anxiety and stress in conjunction with an increased firing 
rate of 5HT neurons in the dorsal raphe nucleus (Gobbi et al, 2005, Blier et al, 2004). 
In addition it has been documented that depressed patients have a higher level of SP in 
their cerebral spinal fluid (CSF) (Bilkei-Gorzo et al, 2002; Santarelli et al, 2001). The 
hypothesis that the TACR1 receptor can modulate the levels of 5HT signalling and 
extracellular levels via secondary messenger mechanisms is also supported by the 
findings that disruption and drug blockage of the Tacrl has no effect on transcription 
regulation or binding potential of the SLC6A4 protein (David et al, 2004).
A regulatory link between SP, Tacrl and 5HT levels is discussed further in the 
relevant chapters of this thesis.
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i. 7 Anxiety and depression
Anxiety is experienced by the majority of people at some point in their lives, 
however, whilst it can be a transient experience it can also present itself as a 
psychiatric disorder that is debilitating for the person concerned. The term anxiety 
disorder covers several different forms of abnormal and pathological fear and 
anxiety. While some categories are well known and may only manifest their effects 
in response to specific stressors (e.g. the phobias), in reality any of the anxiety 
disorders can be chronic in nature and cause physiological responses that are 
distressing and potentially debilitating (difficulty breathing, dizziness, headache, 
sweating, muscles spasms, palpitations and hypertension, nausea, vomiting and 
diarrhoea, sleep problems and cognitive disruptions).
The biological contributors of anxiety disorders are thought to be low levels of 
neurotransmitters specifically, serotonin (5HT) and gamma amino butyric acid 
(GABA), and treatment usually involves the use of the selective serotonin reuptake 
inhibitors (SSRIs) that target the SLC6A4 protein with varying levels of success 
(review, Baldwin etal, 2010).
Anxiety disorders are often accompanied with other mood disorders, particularly 
clinical depression. Research suggests that 60% of people with anxiety disorder will 
also be diagnosed with clinical depression (Cameron, O.G, 2007). This co-morbidity 
may be due to the fact that there is considerable overlap between the symptoms of 
both disorders and the environmental triggers are common risk factors for 
development of these mood disorders (stress, alcohol abuse, substance abuse and 
traumatic events). However, while they share some similar symptoms, such as 
disruption of sleep patterns and reduced sex drive, the behavioural basis of the
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disorders are contrasting. Anxiety disorders have a behavioural basis associated with 
the fear response whereas clinical depression manifests itself with a disruption of 
normal motivations and an inability to experience pleasure. Not surprisingly 
research has focused on the neurotransmitters serotonin and dopamine in the search 
for a biological basis for the progression of, and susceptibility to, depressive 
disorder.
Depressive disorder is a serious disabling condition that can adversely affect a 
person’s life and general health. Depressive disorder is one of the oldest recognised 
mood disorders and is classified in both the International Classification of Diseases 
and the American Psychiatric Associations diagnostic manual. It is also known as 
unipolar depression (or disorder), clinical depression, major depression and recurrent 
depressive disorder. Entire regulatory systems can become dysfunctional and 
sufferers report disruptive sleep patterns, loss of appetite and disruptive eating 
patterns, low self-esteem, lack of interest in previous pleasure activities, low mood 
and withdrawal and isolation from family, friends and work. Since mood disorders 
are highly influenced by both genes and environment research has focused on 
finding the underlying genetic factors that contributed to the development of the 
disorders.
1.8. Mouse models of anxiety and depression like states
The use of mice in in-vivo research usually invokes thoughts of pharmacological 
drag testing or infection with pathogens. What is probably less appreciated is that 
with the right parameters mice can be used as models to study the neurobiological 
mechanisms of depression and related mood disorders. While some depressive
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symptoms are irreproducible in mice (e.g. thoughts of suicide) there are analogues to 
the human symptoms that can be monitored objectively and even be treated and 
reversed by the same drug treatments used for humans. Mice, in particular, exhibit 
anxiety-like behaviours when exposed to certain stressors (new environments, bright 
light, territory intruders). Many of the anxiety behaviours exhibited by mice have 
been improved and even reversed by the same classes of drugs used to treat humans 
and the results are well documented in the literature (Hagenbuch et al, 2006; Gobbi 
and Blier, 2005; Santarelli et al, 2001). The C57BL/6J strain is often used for 
behavioural testing and is well documented to have the most stable and “normal” 
behaviour with a low level of anxiety when compared with other inbred strains 
(Mouse Phenome Database MPD; Festings, 1979).
Regardless of whether the researcher intends to use genetically modified or 
conventional mouse strains it is vitally important to “know thy strain” before any 
behavioural testing is conducted. The Jax lab website has a detailed wealth of 
knowledge on every inbred background of conventional mouse and if the transgenic 
or knockout model is available from the Jax lab they will have an equally impressive 
list of data on these models too.
(www.iax.org/pheiiome; www.iiiformatics.iax.org)
It is important to know what the normal behaviour of the strain is prior to the 
behavioural testing or stressor tests. If a strain that is high for anxiety is used then 
this will just mask the effects of subtle changes due to stressors, genetic 
modifications or the use of pharmacological interventions. In addition, strains with 
poor eyesight are unsuitable for some experiments such as the C3H strain that 
carries the rd (retinal degeneration) gene and is blind after about 6 weeks of age.
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Albino strains too (Balb/C, FVB) all have poor eyesight making them strains to be 
used with care in behavioural studies.
It should also be remembered that other factors such as age, weight, sex, stage of 
oestrous cycle, diet, environmental enrichment and the housing of animals prior to 
an experiment will all have an effect on studies into anxiety and depression like 
behaviours. In particular the females will have a different response to the males and 
are an unsuitable choice for some experiments such as the intruder test or social 
dominance since they are evolutionarily designed to live and breed in large co­
operative groups and very rarely display any intruder or intergroup aggressions and 
anxiety like behaviours.
Observational data can also prove to be valuable such as mouse coat state 
assessment. This can be a quick and qualitative method of assessing mouse 
depression like states as rodents tend to quickly lose coat quality appearance when 
stressed. Part of rodents normal routine is frequent coat grooming both personal and 
intergroup social grooming, stress and anxiety quickly lead to a change in normal 
behaviour with grooming being neglected in a similar- manner to the poor hygiene 
that can be exhibited in depressed patients. The use of antidepressants can reverse 
this abnormal behaviour and quickly improve coat condition (Yalcin et al, 2006). 
Studies have linked a reduction in corticofrophin-releasing factor (CRF) with an 
improvement in coat condition which is relevant to depression like states as 
antidepressants (irnipramine) and anxiolytic (chlordiazepoxide) interact with CRF. 
Therefore, using a scoring system (e.g. Irwin scale) a mouse can have a full 
observational medical prior, during, and after the experimental study which can 
contribute to the experimental data gathered.
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1.8.1 Rodent behavioural tests for anxiety
Rodent tests for anxiety related behaviours are usually based on the conflict inherent 
in approach-avoidance situations. For example, a mouse will have a natural desire to 
explore a new environment for a potential new food source or, even better, a 
potential mate. However, being a highly preyed upon mammal with many predators 
it is reluctant to venture out into open exposed spaces during daylight hours.
To evaluate anxiety levels of mouse strains and knockout lines the light/dark box 
test can be employed which contrasts the animal’s natural instinct to explore its 
suixoundings and environment and its reservation to enter a light illuminated field. 
Animals that spend more time in the dark boxed area compared with the open light 
illuminated area are considered more anxious as they are reluctant to leave the 
security of the dark box (Karl et al 2008, Mathis et al 1994; Crawley and Goodwin 
1980). Mice with lower anxiety levels spend more time in the light area exploring 
the environment in comparison to the mice with high anxiety levels that are reluctant 
to leave the safe dark area of the box. Figure 1.9.
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Figure 1.9. Image reproduced from UCLA behavioural core. The light/dark box test 
evaluates the conflict between the animals instinct to explore with the desire for safe 
refuge and is a standard behavioural test for anxiety.
1.8.2. Rodent behavioural tests for depression
There are a number of tests for depression in rodents including the tail suspension test 
but the most widely used one is the Porsolt forced swim test. These types of tests are 
based on an inescapable aversive situation and measure the animal's behavioural 
despair. The animal’s early cessation of attempts to escape the situation it finds itself 
in is considered a rodent analogue of stress induced depression (Drugan et al 1989; 
Porsolt et al 1977, 1978). Again, the validity of these tests are reinforced by the use of 
antidepressant drugs that increase the time the animal in question spends looking for a 
means of escape. In particular, in the Porsolt forced swim test the time spent 
swimming (looking for escape) is greatly increased in animals that are administered 
antidepressant drugs (Bergner et al. 2010; Holmes et al, 2003). Figure 1.10.
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Figure 1.10. Image reproduced from UCLA behavioural core. The forced swim test 
evaluates the animal’s response to an inescapable aversive situation. Mice are 
placed into a cylinder of water at room temperature and a depth of 50cm from 
which they cannot escape. The time they spend floating as opposed to swimming 
(looking for an escape) is measured over 10 minutes duration.
1.9. Epilepsy and status epileptic us
In recent years there has been a focus on the correlation between depression and 
epilepsy (Chungani et al 2005, Bagdy et al 2006) with particular interest focusing on 
the role of the tachykinins and the NK1 receptors and, more recently, the regulation of 
serotonin levels in the aetiology of epilepsy. Epilepsy is one of the most common 
neurological disorders and is associated with increased hippocampal excitability.
There are over 40 types of epilepsies known (Engel J, 2001) but the most common 
single form of epilepsy is temporal lobe epilepsy (TLE). TLE affects both humans and
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animals and the recurrent epileptic seizures arise in the hippocampus, 
parahippocampal gyrus and amygdala (mesial temporal lobe epilepsy, MTLE).
Once a patient develops epilepsy one of the most distressing symptoms reported is the 
loss of memory and the inability to consolidate short term memory into long term 
(Gaitatzis et al, 2004; Johnson et al, 2004). This is hypothesised to be due to neuronal 
damage in the hippocampus since this is the region of the brain that is vital to memory 
formation. The hippocampus is also the major brain region associated with TLE. It 
can be divided into four fields, CA1 to CA3 and the dentate gyrus which is sometimes 
referred to as CA4 (figure 1.11). KA is known to effect mostly the CA3 region of the 
hippocampus and illicit its effects in the mossy fibres of this area.
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Figure 1.1 L Modified from Ramon and Cajal, 1911. The hippocampus regions CA1 
to 3 and the dentate gyrus (DG) are identified. KA effects mossy fibres in CAS region 
and generates seizures.
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The term Status epilepticus (SE) is often used and refers to a state of severe, repetitive 
seizure activity which often results in neuronal death (De Lorenzo, 1997). Research 
suggests that SE results from excessive stimulation of neurons by the excitatory amino 
acid glutamate but the mechanisms that cause excessive glutamate release still remain 
poorly understood. With this in mind, the neurotoxicant Kainic acid (KA) is 
frequently used as a chemical convulsant in epilepsy studies because it is a glutamate 
receptor agonist and “mimics” the amino acid neurotransmitter glutamate and 
activates its receptors causing a cascade of intracellular events such as, dysregulation 
of glutamate neurotransmissions, alteration of membrane electrophysiology and 
disruption of calcium signalling (Wang et al, 2005; Ben-Ari et alf 2000).
Since the pathological changes in neurotransmitter mediated excitability have been 
correlated to an increase in SP and NKB expression which in turn leads to long lasting 
changes in excitability by further potentiating glutamate release, research has focused 
on the transcriptional regulation of the Tael gene (Wasterlain et al, 2002).
1.10. Role of transcription factors
Transcription factors are proteins that bind specific DNA sequences and contribute 
to the transcriptional regulation of target genes. Whilst many proteins can play 
crucial roles in gene regulation (co activators, chromatin remodelers, histone 
acetylases, deacetylases, kinases and methylases) the transcription factors have the 
defining feature of DNA-binding domains (DBDs) which bind specific sequences of 
DNA adjacent to the genes they regulate (Mitchell and Tjian, 1989). It is estimated
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that 10% of genes in the human genome code for transcription factors and further 
complexity is added by the fact that genes are often flanked by several binding sites 
for distinct transcription factors. Therefore, unique regulation of every gene can be 
achieved by combinational use of the estimated 2000 transcription factors.
Not surprisingly, transcription factors can be highly evolutionarily conserved even 
across distance related organisms. For example the Hox transcription factor family is 
important for determining correct body pattern formation and has been conserved 
from fruit flies to humans (Lemons et al, 2006). Transcription factors can regulate 
the communication between cells by up regulating or down regulating the 
production of signalling molecules. An example of this is the short signalling 
cascade involving oestrogen signalling via the oestrogen receptor transcription 
factor. Oestrogen is secreted by the ovaries and placenta and crosses the cell 
membrane of the recipient cell where it is bound by the oestrogen receptor in the 
cytoplasm. Once activated the oestrogen receptor then enters the cell’s nucleus and 
binds to its specific DNA binding sites and changes the transcriptional regulation of 
the associated genes (Osborne et al, 2001). Transcription factors can also help in the 
response to environmental stimuli such as heat shock factor (HSF) which up 
regulates genes involved in survival at higher temperatures and hypoxia inducible 
factor (HIF) which up regulates genes for cell survival when in low-oxygen 
environments. Transcription factors also regulate the internal cell cycle and when 
they go wrong the results can be disastrous as in the case of oncogenes or tumour 
suppressors.
The transcription factors of particular interest to this thesis are the ones associated 
with the regulation of the Tael gene expression, the repressor element-1 silencing 
transcription factor (REST), a truncated version of REST discovered in rodents
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known as REST4 and the highly conserved activity-dependent neuroprotective 
protein known as ADNP which has recently been suggested as a nuclear 
transcription factor with neuroprotective properties.
1.10.1 REST and REST4
Zinc finger proteins are the most common DNA binding proteins in humans and the 
genes encoding them represent approximately 3% of the genome. These proteins 
contain repeating “finger like” structures formed by the co-ordinate bonding of two 
cysteines and two histidines (C2H2), separated by linker regions of hydrophobic 
amino acids that form positively charged loops that interact with DNA (Wolfe et al., 
2000). REST (also termed neuron restrictive silencing factor, NRSF) is a zinc finger 
protein that is encoded by the REST gene and belongs to the Kruppel-type zinc 
finger transcription factor family. It binds to a conserved 23 bp consensus sequence 
termed neuron restrictive silencer element (NRSE) and it has been observed to be 
dynamically regulated during seizure (Palm et al', 1998).
REST was originally thought to be a repressor of neuronal genes in non neuronal 
cells (Mori et al., 1992; Rraner et al., 1992), however, functional NRSE sites have 
been identified in several genes involved in neuronal function suggesting REST may 
also regulate expression of genes in neurons. REST is also found in undifferentiated 
neuronal progenitor cells and it is thought that it may act as a master negative 
regulator of neurogenesis. REST mediates gene repression by recruiting several 
chromatin-modifying enzymes, decreasing histone acetylation and increasing DNA 
methylation (Ooi and Wood, 2007). Interestingly, splicing variants have been 
observed which may have functional differences from the full length REST protein,
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in particular rodent REST4 and the analogous human sNRSF have been identified 
which contain only five of the eight zinc fingers found in the full length REST and 
as a result they lack the C-temiinal zinc finger repression domain which is 
responsible for recruiting a HDAC complex (histone deacetylase complex) via its 
interaction with CoREST (Balias et al, 2001). It is possible that these variants may 
bind different cofactors to regulate gene expression in a manner that is different 
from the full length REST protein.
The role of REST4 remains debatable, however, there is evidence of it possessing 
anti-silencer function as it is able to interact with REST to antagonise its repression 
activity of the gene encoding choline acetyltransferase in PC 12 cells (Roopra et al., 
2001; Shimojo et al., 1999). EMSA has shown that REST4 can interact with NRSE 
domains but with a 10-20 fold lower interaction than the full length REST, however, 
overexpression of REST4 resulted in alleviated repression of BDNF (brain derived 
neurotrophic factor) in cortical neurons (Tabuchi et al, 2002; Palm et al, 1998).
The TAC1 promoter contains a NRSE consensus sequence adjacent to the start of 
transcription and REST has been previously shown to regulate the Tael gene in 
vitro models (Quinn et al, 2002). Particularly relevant to this thesis is the fact that 
two REST isofonns are induced and differentially regulated in response to seizures 
in rodents (Palm et al, 1998) and our group have previously postulated that REST is 
a key candidate to regulate Tael gene expression during epilepsy with an interplay 
between REST and REST4 (Spencer et al, 2006; Quinn et al, 2002).
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L10.2ADNP
ADNP is regulated by the 28 amino acid peptide VIP (vasoactive intestinal peptide). 
VIP was first isolated from the small intestine of pigs because of its ability to cause 
vasodilation (Said and Mutt, 1970) but despite its name it is also expressed in the 
brain. ADNP is known to be essential for accurate brain formation during 
development and is abundantly expressed in the adult brain suggesting a continuing 
important role post gestational (Gennet et al> 2008).
ADNP has been hypothesised to mediate VIP induced neuroprotection due to the fact 
that a synthetic peptide (NAP, eight amino acids in length) derived from the ADNP 
protein sequence has been shown to have highly neuroprotective effects in vitro 
(Gozes etal, 2000).
As well as a hypothesised role in neuronal protection as a result of trauma or insult, 
ADNP has been shown to protect against some forms of excitotoxicity which is a term 
given to the neuronal damage that results from over stimulation of excitatory 
transmitters such as glutamate (Gozes et al, 2000; Bassan et al, 1999). Since 
excitotoxicity is implicated in epilepsy the dynamic regulation of ADNP in our mouse 
models was of particular interest to this thesis and this is explored further in Chapter 
three.
1.10.3 Thesis hypothesis
Previous studies have revealed a role for the tachykinins in anxiety, depression and 
also epilepsy, however, conflicting publications suggest that the redundancy 
phenomena may be an issue when using the single knockouts for this area of research. 
It was hypothesised that the generation of a “double knockout” mouse model with a 
disruption of the preferred receptor/ligand pathway of B6.Cg-7hc7 x B6.Cg-
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Tacrltmiuci/J would reveal that a level of redundancy is present in the contributing 
parental single knockout lines of B6.Cg-Tacl tmlmmh/j and B6.Cg-Tacrltmiuci!J when 
subjected to behavioural and pharmacological testing.
The use of the single knockouts in previous studies in our laboratory had also revealed 
a potential model of seizure resistance with modulation of the Tad gene via the 
transcription factors REST and REST4 with ADNP being implicated as having a 
neuroprotective role in the experimental models used.
The generation and use of the mouse models in this thesis intended to address the 
hypothesis that the transcription factors REST and REST4 are differentially 
modulated in the double knockout and single knockout lines of B6.Cg-7ac7 tmlnmhl] 
and B6.Cg~Tacrhmiuci!] in an experimental mouse model for TEE using the 
neurotoxicant Kainic acid (KA).
The same models would be utilised to explore the role of ADNP and address the 
hypothesis that it is differentially modulated in the double knockout and single 
knockout lines of B6.Cg-7ac7 !mlwmhi] and B6.Cg-Tacrltmhtcil] in an experimental 
mouse model for TLE using the neurotoxicant Kainic acid (KA) that may allude to its 
neuroprotective properties against excitotoxicity.
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1.11 Mouse nomenclature
In conclusion for the introduction chapter of this thesis I would like to give a very 
brief overview of mouse nomenclature. As mentioned previously, nomenclature is 
vitally important when using mouse strains for their correct identification but also 
for replication studies. For this reason it is appropriate to review the rules and 
meaning behind the internationally standardised nomenclature that is used not only 
for existing mouse strains but also for the generation of new and novel mouse 
models.
Inbred strains of mice are ones that have been inbred by filial mating (brother x 
sister) for at least 20 consecutive generations. They were originally created for an 
expression of a trait with the aim of making the trait as consistent as possible by 
removing genetic variance.
Most commercial laboratories originally obtained their mice from Jax labs but then 
continued to maintain the line themselves with brother x sister matings. Since it is 
estimated that a spontaneous mutation can aiise on average every 7 generations 
(Drake et al, 1998) the vast majority of commercial suppliers have a unique genetic 
and phenotypic substrain of the original Jax lab strain. Thus it is very important to 
put in the nomenclature for the lab maintaining the strain as this can tell the 
researcher the exact subshain of mouse used in studies (figure 1.12).
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A) . Typical inbred line =
Miss Abbie Lathrop's “pet shop” stock C.C. Little (1921) mating of female 57 
C57BL (B!ack)/C57BR (Brown)/C57L (Leaden).
C57BL/6J (6 is substrain of original C57BL line and J denotes Jax labs)
B) . Spontaneous mutation = 129P3/J-Le/nw/>-3.//J =
(Background Strain) (Gene Affected) (Allele designation) (Lab Maintaining 
Strain)
C) . Knockout mouse line - B6;129P2-/72f//;i/WJ =
(Background (mixed) (Targeted gene) (Targeted mutation) (Allele 
designation) (Lab registration code) (Lab maintaining strain)
D) . Transgenic mouse line = C57BL/6-Tg(CAG-EGFP)10sb/J —
(Background Strain) (Transgenic) (Promoter) (Gene expressed) (Founder line 
number) (Lab registration code) (Lab Maintaining Strain)
Figure 1.12. A). Shows the origin of the letters and numbers used in a common 
inbred line. What is important is the letters after the C57BL/6 as these will indicate 
the laboratory maintaining the line and therefore the genetics. B). Shows correct 
nomenclature to be used (colour coded) when spontaneous mutation has arisen and 
is bred for its phenotype. C). Correct nomenclature for knockout (tm = targeted 
mutation) again colour coded. D). Correct nomenclature for transgenic line (Tg) all 
colour coded.
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There are numerous examples on the Jax lab website and MGI website on the 
genetic and phenotypic differences between the sub strains of mice that originally 
came Ifom one line. To give an example of how this can impact a researcher’s work 
we will look at two lines of C57BL/6J.
C57BL/6J = maintained by Jax labs 
C57BL/6J01aHsd = maintained by Harlan UK
On the face of it they appear to be both C57BL/6J but the second strain has been 
maintained at Harlan for over 20 generations and this strain has developed a 
mutation which has resulted in a deletion of Snca gene that is now homozygous 
throughout the entire colony. The Jax lab BL6J remains wildtype for the Snca gene. 
The SNCA protein (presynaptic protein a-synuclein) is implicated in a range of 
neurodegenerative diseases and is the primary structural component of Lewy bodies 
found in Parkinson’s disease brains. Therefore, if these two strains of mice were 
used in neurological behavioural studies, or were used for backcrossing of a 
knockout or transgenic line onto C57BL/6J they would have very different genetics 
and potentially very different phenotypes as it has been documented that the Harlan 
BL6 strain has an alteration of dopamine release in the nigrostriatal system (Specht 
and Schoepfer, 2001).
Although descended from the same inbred strain the substrains that exist may have 
very different phenotypes. The longer the strain has been maintained without 
replenishing the genetics the further apart from the original strain it will genetically 
drift. This is especially important for knockout and transgenic strains that have the 
further complication and variability with the flanking gene sequences around the 
locus of the genetic modification.
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CHAPTER 2: MATERIALS AND METHODS
2.1 Materials
2.1.1 Commonly used solutions and reagents 
Luria broth (LB) media
10.0g/l peptone, 5.0g/l yeast extract, and 10.0g/l NaCl
LB Agar
10.0g/l peptone, 5.0g/l yeast extract, and 12g/l agar
5x TBE buffer
54g Tris(hydroxymethyl)methylamine (Tris) (BDH), 27.5g boric acid (VWR 
International), 20ml 0.5M Ethylenediamine Tetmacetic Acid (EDTA) (Sigma) and 
dEhO up to 1 litre
Tris-buffered saline (TBS)
137mM NaCl (BDH), 27mM KC1 (Sigma) and 25mM Tris (BDH) to a total volume 
of 1 litre. The pH is adjusted to pH7.4
6x agarose gel loading buffer
0.25% (w/v) Bromophenol blue, 0.25% (w/v) xylene cyanol, ImM EDTA, 30% 
glycerol and 70% water.
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Selective antibiotics
Ampicillin. Ampicillin sodimn salt dissolved in water as lOOOx stock (concentration 
lOOmg/ml) and stored at -20°C. For positive selection of bacteria containing a plasmid 
with ampicillin resistance gene [3-lactamase, growth media or plates supplemented 
with Igl/ml of ampicillin stock to give a concentration of lOOpg/ml.
Kanamycin. Kanamycin monosodium salt dissolved in water as lOOOx stock 
(concentration 25mg/ml) and stored at -20°C. Ijal/ml of kanamycin stock was added 
to growth media or plates to give a final concentration of 25pg/ml.
2.2. Animals
Animals were utilised from Biomedical Services Unit, University of Liverpool and 
culled under local and national schedule one guidelines. All procedures were carried 
out according to home office licences and regulations. Transgenic mice analysis 
involved the use of Tael and Tacrl knockout transgenic lines on a C57BL/6J 
background. Transient transgenics were generated as described in 2.3 of this chapter. 
All animals were bred in house under licence procedures except for the wildtype 
C57BL/6J controls that were purchased from Charles River UK and allowed to settle 
for a minimum 7 day period prior to use.
Mice were weaned at 19 to 21 days and group housed in their litter mate pairs males 
and females up to 6 in a cage. Light/dark cycle was summer time setting 12 hours 
light 12 hours dark on a 7am to 7pm cycle. Relative humidity was 45 to 55% and food 
and water was provided ad libitum. Food was standard chow (SDS pellet CRM). All 
animals used were adult and sexually mature with the exception of the transient 
transgenic embryos.
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2.2.1. Removal of tail tips for genotyping
Removal of no more than 0.5cm of tail tip was done under general anaesthesia via gas 
anaesthetics trolley using Isoflurane and oxygen mix at 4-5% induction and 3-4% 
maintenance (1:4 millilitres per minute concentration respectfully). Ear punching 
identification was applied whilst still under anaesthesia (3Rs - refinement). Tail tips 
were frozen in 1ml ependoffs at -20°C and individually identified.
2.2.2. Isolation of genomic DNA from tail tips
Add 500jrl of tail tip buffer plus 200|il of Proteinase K to each tail tip and incubate 
overnight at 55°C in water bath.
Freeze at -20°C for 20-30 minutes.
Spin down in cold room at 13,000 rpm for 10-15 minutes (keep on ice).
DNA precipitation. Transfer 360jil of supernatant to fresh eppendoff (freeze 
remaining tail tip sample).
Add 40(11 of 3M sodium acetate pH7.
Add 40 pi of isopropanol.
Mix (DNA should now be seen as white precipitate).
Spin briefly (30 secs) at 13,000 ipm.
Remove supernatant and gently re-suspend DNA pellet in 80% alcohol (500pl).
Spin briefly (30 secs) at 13,000 rpm and remove supernatant.
Air dry pellet at room temperature (do not allow DNA pellet to dry out completely or 
it will be difficult to re-suspend it).
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Re-suspend in 200|j,l TE buffer pH8.
The DNA can now be analyzed or frozen at -20°C (can be defrosted and re-ffozen 
several times).
2.2.3. Stimuli
5mM Kainic acid
10 mg kainic acid (Sigma) in lOmls dt^O, dissolve by gentle mixing and warming. 
Kainic acid very difficult to dissolve and is aided by heating to 37°C in incubator and 
use immediately. Discard any unused solution. Weigh animals and dose at selected 
concentration.
2.3 Methods
2.3.1 Kainic acid Induction of Seizures in mice
Transgenic and knockout mice were used as described in chapter five (Tael null, 
Tacrl null, double knockouts null for both Tael and Tacrl, and wildtype C57BL/6J), 
encoding regions were generated previously and backcrossed onto C57BL/6J 
background (Cao et al, 1998; Zimmer et aL, 1998; Carmen De Felipe et al, 1998). 
Adult mice were administered with 17mg/kg i.p of kainic acid in saline or saline alone 
as a control. Behavioural responses to KA were scored by means of elaboration of the 
methods described by (Morrison et al, 1996). Seizure severity was recorded over a 
period of 90 minutes using an extended version of the Racine scale as follows. 0 = 
normal, 2 - staling, panting, frozen, 4 = head tossing, wet dog shakes, 6 = short 
myoclonic jerks, excessive scratching, tail rigidity, 8 = short forelimb clonus,
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hunchback posture, 10 = loss of balance, hindlimb clonus, rearing, 12 = continuous 
forelimb clonus, discrete rearing and falling episodes, 14 = continuous rearing and 
falling, barrel rotations (full seizure), 16 = death. Following 90 minutes mice were 
administered with lOmg/kg i.p diazepam to arrest seizure activity. At 3 hours, 24 
hours, 4 days and 7 days post SE mice were euthanased and the right hippocampus 
was removed from the right hemisphere and snap frozen in liquid nitrogen for RNA 
extraction.
2.3.2 The Racine scale of seizures (Racine, 1972)
Stage Seizure type
1 Mouth and facial movements
2 Head nodding
3 Forelimb clonus
4 Rearing
5 Rearing and falling
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Extended Racine scale for behavioural scoring:-
0 = normal,
2 = staring, panting, frozen,
4 = head tossing, wet dog shakes,
6 = short myoclonic jerks, excessive scratching, tail rigidity,
8 = short forelimb clonus, hunchback posture,
10 = loss of balance, hindlimb clonus, rearing,
12 = continuous forelimb clonus, discrete rearing and falling episodes, 
14 = continuous rearing and falling, barrel rotations (full seizure),
16=death
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2.3.3 Anaesthesia
Injectable for oviduct transfer (hypnorm and valium). Hypnonn injected 
intraperitoneally at 0.01ml/30g mouse, diazepam (valium) injected intra muscularly at 
5mg/Kg body weight. Mouse remains anaesthetised for 30 to 40 minutes but has a 
sleep time of up to 2 hours during which time they must be kept warm using heat pad 
or heated recovery room.
Gaseous for tail tip amputation (Isoflurane and oxygen). Isoflurane anaesthesia 
induction at 4-5% mix and maintenance at 3-4% mix with oxygen.
2.3.4 Analgesia
Buprenorphine (temgesic). Dose for mice is 0.5-lmg/Kg. Weigh mouse and inject 
appropriate dose sub-cutaneously during anaesthesia sleep time. This may prolong the 
sleep time of the mouse. Check mouse regularly and dose every 12 hours if required.
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2.4 Cloning of standards
2.4.1 Analysis of DNA using Agarose Gel-Electrophoresis
For the analysis of PCR products from reactions (section 2.2.10) or 
fragments generated by restriction digests (section 2.2.14), agarose gel- 
electrophoresis was employed. 1% agarose (multi-purpose agarose, 
Bioline) was melted in 0.5x TBE buffer and supplemented with 2-4j.il 
ethidium bromide (lOmg/ml aqueous solution, Sigma). Gels of 150ml were 
cast in 12x14cm or 20.5x10cm trays; 50ml gels were cast in 7x10cm trays, 
and appropriate combs inserted. After allowing the gels to set for 1 hour at 
RT, the gels were submerged in horizontal gel electrophoresis tanks 
(Hybaid turn and cast submarine gel system, Hybaid, or Savant HG 350 
tank) containing 0.5x TBE buffer. Samples were mixed with 6x loading 
buffer and loaded into the wells. A DNA ladder (typically mass ruler, 
Fennentas) was also loaded, to size the products or fragments of the 
samples. 150ml gels were generally run at 120-150V/cm (Hybaid). The 
electrophoretically separated samples were visualised with an Evenscan 
broadband dual wavelength transluminator in a Multiftnagell Light 
Cabinet (both Alpha Innotech Corporation) at a wavelength of 302mn. 
Permanent records were taken with a CCD camera (Alpha Innotech 
Corporation) and stored electronically.
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2.5. Restriction endonuclease digest
Restriction enzyme digests were carried out in lx restriction enzyme buffer 
with the addition of BSA. The digests were carried out at the appropriate 
temperature for the respective enzyme for a minimum of 90 minutes. For 
double digests with enzymes requiring distinct buffers, the DNA was 
purified from the first reaction using a Qiaquick Spin Column (Qiagen) 
according to the manufacturer’s protocol after the first digest. The second 
digest was set up adjusted to the volume of the eluate. Enzymes were 
mostly obtained from Promega, or alternatively from New England 
Biolabs.
2.6 Sequencing
DNA sequencing was performed by The Sequencing Service (School of 
Life Sciences, University of Dundee, Scotland); using Applied Biosystems 
Big-Dye Ver3.1 chemistry on an Applied Biosystems model 3730 
automated capillary DNA sequencer.
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2.7 Immunohistology
2.7.1 Processing of tissue from animal model
Brains were extracted manually and fixed in 4% buffered PFA as 
indicated. The brains were cut into slices of 2 mm thickness with the aid of 
a rat brain blocker, and were embedded in paraffin wax. 3-5pm thick, 
consecutive sections were cut and placed on polylysine-coated slides 
(BDH Laboratory Supplies, Lutterworth, UK). Brain sections were dried 
onto the slides at 37°C overnight, and deparaffmised for 2 x 5 minutes in 
100% xylene. Slides were re-hydrated for 2x5 minutes in 100% 
isopropanol and 5 minutes in 96% ethanol. Slides used for 
immunohistological analysis were then stained with Papanicolaou’s 
haematoxylin-eosin followed by blueing in tap-water, and were then 
preserved with DPX and cover slipped. Consecutive sections were 
deparaffinised and rehydrated in the same way, but instead of 
haematoxylin-eosin staining, they were used for immunostaining as 
described below.
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2.7.2. Immunohistological staining of paraffin-embedded tissue 
sections
Immunohistology for ADNP was performed, using rabbit anti-ADNP Ig 
(Chemicon) and the peroxidise anti-peroxidase (PAP) method, adapting 
previously published protocols for polyclonal antibodies (Kipar et al., 
1998).
Immunohistology for REST and REST4 was performed using the rabbit 
antirat antibodies (Sigma) and peroxidise antiperoxidase (PAP) method. 
Briefly, after the rehydration step in 96% ethanol, endogenous peroxidase 
activity was blocked for 30 minutes with 0.5% H2O2 in 100% methanol. 
Slides were then washed with TBS and inserted into Sequenza- 
immunostaining racks, followed by a further wash with TBS. Sections 
were then blocked with 1:2 non-specific swine serum in TBS, lOOpl per 
slide. REST, REST 4 and ADNP antibodies were prepared in TBS with 
20% swine serum, at a dilution of 1:100. lOOjrl of diluted antibody were 
added to each racked slide, and left to incubate at 4°C overnight. The 
following day, the slides were washed for 5 minutes, 3 times in TBS, and 
then incubated for 30 minutes in swine anti-rabbit IgG at a dilution of 
1:100, prepared in TBS with 20% swine serum. The slides were washed 
again for 5 minutes in changes of TBS, and incubated for 30 minutes in 
PAP (peroxidase-anti-peroxidase) rabbit complex, diluted 1:100 in TBS 
with 20% swine serum. After 5 minutes of washes in TBS, the slides were 
removed from the immunostaining-racks, and placed in water. The slides
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were then incubated for 5 minutes with stilling in freshly prepared 
diaminobenzidin (DAB) solution with 0.01% H2O2. Finally, the slides were 
then transferred back into water, followed by 3 washes of 5 minutes in 
TBS, and one in water. The slides were then dehydrated in ascending 
concentrations of ethanol (70%-96%), followed by three washes in xylene. 
Sections were preserved in DPX and cover slipped. Consecutive sections 
incubated with normal rabbit serum instead of the primary antibody served 
as negative controls.
2.8. Standard Polymerase Chain Reaction (PCR)
PCR was used as a method for amplifying DNA fragments for use in 
molecular cloning. PCR was performed in a PxE thermal cycler (Thermo 
Electron Corporation) or Hybrid Sprint thermal cycler. 50pi PCR reactions 
included 10-100ng DNA template, 2mM MgCk, 0.2 mM of each dNTP, 
0.2pi of each primer, lx diamond buffer and 1.5 units of diamond DNA 
polymerase.
2.8.1 Annealing temperature (Tm)
Tm is the most critical factor governing the specificity of a PCR reaction 
and was calculated according to the formula:
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60 + (0.41 x %GC content) — 675/n (were n = number of nucleotides). 
Concentration was detennined using spectrophotometer at 260nm: 
pg/ml = A260 x pg per OD x dilution factor.
Total pg was then used to calculate pinoles: 
pmoles = total pg/MWT.
2.8.2 PCR primer design
Primers were designed, in general, to be between 20 to 25bp long, melting 
temperatures of 50-65c'C, with GC content between 40-60%.
2.8.3 PCR purification
To purify the double stranded DNA fragments from PCR and other 
enzymatic reactions the QIAquick PCR purification kit was used following 
manufacturer’s instructions.
2.9 Statistics
All results are presented as mean ± standard error of the mean (standard 
deviation) were appropriate; comparisons were made as appropriate using 
the Student t-test in Microsoft Excel. Significant differences were 
identified at a value of p<0.05 significant, p<0.01 highly significant and 
p<0,005 very highly.
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Chapter Three: Generation of double knockout for the 
Tael/ Tacrl pathway and subsequent phenotyping of the 
model.
3.1 Introduction
Pre-existing knockout mouse models described previously were used to 
generate a double knockout mouse model that had a preferred ligand and 
receptor pathway disrupted. This double knockout was generated in order 
to investigate the issue of redundancy in the contributing parental single 
knockout lines, the rationale being that a mouse line whose endogenous 
signalling pathway of SP and Tacrl was disrupted simultaneously would 
display a more substantial phenotype in comparison to the single knockout 
lines.
During its generation it was hypothesised that there may be an obvious 
phenotype due to the abolition of a preferred ligand and receptor pathway. 
It was even considered that the double knockout may be embryonic lethal 
and alternative breeding strategies were contemplated for generation of the 
model in the eventuality of such an outcome. The double knockout was 
generated and its statistical occurrence was compliant with Mendelian trait 
predictions, however, it soon became apparent that the double knockout
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model was displaying an interesting phenotype. The double knockout of 
Tael-/- x Tacrl-/- was on a C57BL/6J background as were the single 
knockouts that had previously been well characterised with regards anxiety 
and depression like behaviours (Bilkei-Gorzo et al> 2002; Zimmer et al, 
1998; Carmen De Felipe et al, 1998) as well as a resistance to chemically 
induced seizure (Liu et al, 1999a; Cao et al, 1998). Therefore, there was an 
opportunity to characterise and validate this double knockout model 
especially in light of the redundancy issue discussed in the introduction 
(1.5.8) and consequently this model was subjected to various behavioural 
tests and ultimately pharmacological experimentation.
As previously mentioned in this chapter introduction, TACR1 antagonists 
showed promise as an intermittent drug treatment for anxiety and 
depression to increase 5HT levels on a short term basis while waiting for 
the effects of widely used medications, like the SSRIs or tricyclics, to 
commence (Gobbi and Blier, 2005; Kramer et al, 1998). The double 
knockouts behavioural response to anxiety and depression like states was 
assessed in comparison to the individual knockouts for Tacrl and Tael. 
Animal models are widely used to study the neurobiological mechanisms 
of depression and anxiety. Mice, in particular, exhibit robust anxiety like 
behaviours in the appropriate field tests. Indeed, the pharmacological 
mechanisms of psychoactive drug responses are similar across many 
mammalian species confirming a common conserved behavioural response
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to certain stimuli (review, Bergner et al, 2010). The double knockout was 
compared and contrasted with the single knockouts in a behavioural test for 
anxiety (light/dark box) and a behavioural test for an animal analogue of 
depression (Porsolt forced swim test).
3.2 Hypothesis
The double knockout would display a more substantial phenotype in the 
behavioural tests in comparison to the single knockouts which may be 
attributed to redundancy effects in the single knockouts given the level of 
interaction that is evident across related neuropeptides and preferred 
receptors.
The double knockout would display a distinct phenotype that is in contrast 
to the single knockouts in a pharmacological experimental model for TLE 
with the use of the neurotoxicant Kainic acid.
3.3 Aims
To generate a double knockout mouse model that had the endogenous 
signalling pathway of SP from the Tael gene and its preferred receptor 
Tacrl disrupted to investigate the issue of redundancy in the parental single 
knockout lines.
To validate the double knockout model in comparison to the single 
knockout lines that were utilised for its generation as well as the wildtype
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background strain (C57BL/6J) in behavioural studies for anxiety and 
depression in order to assess level of redundancy (if any) and also the 
hypothesised regulatory link between the SP/Tacrl pathway and 5HT.
To validate the double knockout model in comparison to the single 
knockout lines which have been documented to be resistant to chemically 
induced seizures using the neurotoxicant kainic acid.
To investigate the expression of transcription factors post kainic acid 
treatment in the double knockout and single knockout mouse models. The 
transcription factors REST and REST4 are known to be dynamically 
regulated in seizure activity and also modulate neuropeptide expression.
To investigate the expression of a protein in the double and single 
knockout mouse models post kainic acid treatment. The protein, ADNP, 
has been hypothesised to have neuronal protective properties during 
seizure.
To investigate the sex dependant differences that became apparent during 
the kainic acid experiments.
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To ultimately contribute knowledge to the tachykinin signalling pathway 
with regards the mood disorders and contribute an explanation for the 
conflicting results in peer reviewed literature.
To ultimately contribute knowledge to the regulatory role SP plays in the 
well documented neurological disorder, epilepsy, which is correlated with 
the mood disorders,
3.4 Methods
Animals.
All mice used were C57BL/6J wild types or GA mice whose background 
strain is C57BL/6J (BL6). All mice where aged 12 to 16 weeks old (adult 
and sexually mature) and were group housed on a 12/12 light dark cycle 
with access to food and water ad libitum, relative humidity 40-55%.
Strains used.
Tael-/- mouse kindly donated by Andreas Zimmer, University of Bonn 
(Zimmer et al 1998). Tacrl-/- mouse kindly donated by Steve Hunt, UCL 
(Laird et al 2000; Carmen De Felipe et al, 1998). C57BL/6J wild types 
purchased from Charles River LTD.
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GA mice generated. Tael-/- x Tacrl-/- double knockout generated by 
selective cross breeding of the above strains to produce a mouse that is null 
for the SP/Tacrl pathway.
Screening for double knockout.
Tael knockout males and Tacrl knockout females were bred together to 
produce an FI generation that carried each of the deletions heterozygously. 
The FIs were then backcrossed to Tael knockout mice to produce an F2 
generation 25% of which were homozygous for the Tael deletion and 
heterozygous for the Tacrl deletion. Males and females of this genotype 
were then bred together and 25% of their offspring were the double 
knockout genotype that we were looking for. This method of breeding 
greatly reduces the number of mice needed to achieve generation of a 
double knockout and reduces waste of genotypes that are non-desirable. 
This method also enhances the chances of generating a double knockout 
that may be physiologically challenged as the ratio is always 1 in 4 for the 
desired genotype as opposed to 1 in 16 if the heterozygous FI generation 
where bred together. This is consistent with the aims of the 3Rs 
(replacement, reduction, refinement). All offspring had less than 0.5cm of 
their tail removed under general gaseous anaesthetic using Isoflurane at 3- 
4% mix with oxygen, bleeding was controlled by cauterisation and mice 
were ear marked with unique identifications all while still under
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anaesthesia {replacement, reduction, refinement; Russell and Burch, 1959). 
DNA was extracted from the tail samples by overnight digestion in tail tip 
buffer and PCR performed for Tael and Tacrl separately on all samples 
using the following primers;
Tacrl primers,
NK-lFwd 5-CTGTGGACTCTGATCTCTTCC -3’ 
NK-lRev 5’-ACAGCTGTCATGGAGTAGATAC -3', 
NeoFwd 5’- GCAGCGCATCGCCTTCTATC -3';
Tael primers,
Tael common (AZ95) S’-GCC TTT AAC AGG GCC ACT TGT TTT 
TCA ATT-3’,
Tael knockout (CNK04) 5’-ACT GTG GTT TCC AAA TGT GTC AGT 
T-3’,
Tael wildtype (AZ99) 5’-AGA CCC AAG CCT CAG CAG TTC TTT 
GGA TTA ATG-3\
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Behavioural testing.
All behavioural testing was prefonned blind. The four lines of mice were 
identified only by numbers 1 to 4 and behavioural testing conducted 
without the knowledge of which line were the wildtypes, single knockouts 
or double knockouts.
All lines were subjected to Porsolt forced swim test (Dmgan et al 1989; 
Porsolt et al 1977, 1978) to evaluate stress induced depression, and 
light/dark box exploratory test (Mathis et al 1994; Crawley and Goodwin 
1980) to evaluate anxiety levels. As previously described, mice from all the 
strains were placed into a large open cage half of which was illuminated 
with an overhead lamp, the other half had a box covering it so it was dark 
inside with a small opening for the mice to exit in and out of the box.
Statistical analysis was done in excel using the students t-test for all the 
lines in comparison to the wildtype control.
Chemically induced seizures.
All testing was preformed blind. The four lines of mice were identified 
only by numbers 1 to 4 and chemically induced seizures evaluated without 
the knowledge of which line were the wildtypes, single knockouts or 
double knockouts.
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A dose-response curve was constructed for BL6 wild type mice to 
ascertain what dose of kainic acid (KA) would not cause a full seizure but 
would induce mild seizures and behavioural changes that could be 
evaluated in all the strains. Males and females were paired together in 
batches, the dosage range was: 15mg/Kg, 25mg/Kg and 35mg/Kg. 
Following seizure severity scoring a dose of 17mg/Kg was chosen, 
however, it became clear when assessing the dose-response curve that there 
were distinct gender differences in the behavioural response and sensitivity 
to KA injection between the sexes. The decision was taken to expand the 
study and analyse the males and females separately but using the same 
17mg/Kg dose.
All strains were then injected intraperitoneally (IP) with 17mg/Kg of KA 
and seizure activity was scored using the Racine scale for seizure severity 
(Racine 1972). Seizure severity was recorded over a period of 90 minutes 
post injection using an extended version of the Racine scale as follows
0 = normal,
2 = staring, panting, frozen,
4 = head tossing, wet dog shakes,
6 = short myoclonic jerks, excessive scratching, tail rigidity,
8 = short forelimb clonus, hunchback posture,
10 = loss of balance, hindlimb clonus, rearing,
12 = continuous forelimb clonus, discrete rearing and falling episodes,
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14 = continuous rearing and falling, barrel rotations (full seizure),
16 = death.
Statistical analysis was done in excel using the students t-test for all the 
lines in comparison to the wildtype control
Tissue collection and processing.
All mice were allowed to recover from seizures and were humanely culled 
via a schedule one technique (Schl) and brains removed at the following 
time points post injection: 3 hours, 24 hours, 4 days and 7 days (n=3-4 per 
group) time course intervals for histology were based on previous research 
which revealed KA induced damage in adult C57BL/6J mice by 12 hours 
following treatment (Benkovic et al, 2006). The brains were bisected and 
one half fixed in 4% paraformaldehyde, embedded in wax, sections taken 
of hippocampus and every other stained with haematoxylin and eosin (HE) 
and the rest used in immunohistology. The other half was snap frozen in 
liquid nitrogen and stored in -80 freezers for future rtPCR. See methods 
and materials section for protocols.
Immunohistology,
Sections from the above time point (n~3-4 per group) were immunostained 
(see methods and materials) for the following; REST, REST4 and ADNP 
(activity-dependent neuroprotective protein).
81
Statistical analysis.
Differences between means were analysed in excel using the Students t-test 
and were considered different when probability values were less than 0.05.
3.5 Results
3.5.1 The light/dark box test for anxiety
The strain showing the highest anxiety levels were the C57BL/6J 
wildtypes. The strain with the lowest anxiety score by far was the Tacrl-/- 
mice with statistical significance in comparison to the wildtype controls 
(see figure 3.1), which is consistent with the published literature (Rodgers 
etal, 2004; Santarelli etal, 2001).
The double knockout also demonstrated a lower level of anxiety in 
comparison to the wildtype controls that was statistically significant but not 
to the extent of the Tacrl single knockout (figure 3.1).
The Tael-/- mice displayed lower anxiety levels compared to wild type 
figure 3.1) but it was not statistically significant, however it should be 
noted that this model has documented lower levels of anxiety in the 
literature (Zimmer et al, 1998) and it may be that increasing the n number 
would show a statistical difference in comparison to the wildtype strain.
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Light/dark box test
**
Figure 3.1 Light-Dark Box Analysis (n=5).
The Tacrl (NK1) knockouts and the double knockouts showed lowered 
anxiety levels in comparison to the wildtype controls. The TAC1KO were 
not statistically different to wild type animals. Student t-test used were 
*=p<0.05 considered significant and **-p<0.01 considered highly 
significant.
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3.5.2 The Porsolt forced swim test for stress induced depression 
Consistent with previous data on individual Tael-/- or Tacrl-/-, the single 
knockout animals tested swam for a greater duration of time than their wild 
type controls indicating a resistance to stress induced depression (Bilkei- 
Gorzo et al, 2002). However, the double knockout strain was surprisingly 
the least active suggesting that this strain is prone to stress induced 
depression (figure 3.2).
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Figure 3.2. Porsolt Forced Swim test (n=5).
Transgenic strains where compared to the C57BL6 wild type (WTs). The 
Tael and Tacrl (NK1) knockouts were the most active compared to the 
wildtypes with a high significance. Surprisingly the double knockout mice 
were the least active and showed a statistical significant tendency to stress 
induced depression. Student t-test used were *=p<0.05 considered 
significant and **=p<0.01 considered highly significant.
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3.5.3 Pharmacological model ofTLE (temporal lobe epilepsy)
The final test was to address the response of all the strains of animals to 
chemically induced epileptic seizures initiated by Kainic acid (Benkovic et 
al, 2006). Males and females were paired in batches together for the dose 
range study to determine an appropriate dose of Kainic acid (KA) for this 
study; however it became very clear that there were distinct gender 
differences in the behavioural response and sensitivity to KA injection 
between the sexes (figure 3.6). Therefore we expanded on the 
experimental design in order to address the gender differences by 
separating the males and females. To try and observe differences in the 
behavioural response of the lines we used the lowest range of KA, from 
figure 3.3, to highlight any increased susceptibility. Under these 
conditions for the males we saw increased susceptibility only the double 
KO line (figure 3.4). For the females, however, all the lines showed an 
increased susceptibility at this low dose of KA when compared to their 
male counterparts (figure 3.6).
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3.5.4 Chemically induced seizures using KA
Dose Range Males v Females
2000 -
15mg/Kg 25mg/Kg 35mg/Kg
Kainic Acid Dose
Males
Females
Figure 3.3. Dose range study (n=3).
Demonstrates the difference between the sexes at the lower dose but this
difference disappears at higher doses. Statistical analysis not appropriate 
as this was a dose range study. 17mg/Kg chosen on observations of 
behaviour as 15mg/Kg was considered too low but 25mg/Kg was too high.
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Kainicacid males experiment
Figure 3.4. KA induced SSSE in males, dose 17mg/Kg (n=5).
All mice injected IP with 17mg/Kg KA and severity was scored for 90 
minutes post injection using the Racine scale. The Tacrl (NKI) and Tael 
knockouts have a score comparable to their wild type controls (WTs), but 
the double knockouts had an unexpected full seizure even at this low dose 
that is statistically significant in comparison to their WT controls. Student 
t-test used were *=p<0.05 considered significant and **=p<0.01 
considered highly significant.
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Figure 3.5. KA induced SSSE in females, dose 17mg/Kg (n=5).
Seizure severity was scored for 90 minutes post IP injection using the 
Racine scale. The females of all the strains, including wild types, showed a 
greater sensitivity to KA injection. Although the double knockout was the 
most sensitive in comparison to its WT controls it was not statistically 
significant. Student t-test used were *=p<0.05 considered significant and 
**=p<0.01 considered highly significant.
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The females of all the lines showed a greater sensitivity to the KA induced 
seizures (see figure 3.5). This became more apparent when the males were 
compared to the females on the same graph and analysed statistically using 
the student t-test to compare the sexes of each strain (figure 3.6).
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Figure 3.6. Comparison of male versus female mice injected IP with 
17mg/Kg KA (n=5).
Seizure severity was scored for 90 minutes post injection using the Racine 
scale. When the males vs. females are compared together the difference 
can be seen with all four lines (WT, Tael-/-, Tacrl (NK1-/-) and double 
knockout) with statistical significance in comparison to their sexual 
counterparts. Student t-test used were *=p<0.05 considered significant, 
**=p<0.01 considered highly significant and ***=p<0.001 considered 
very highly significant.
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3.5.5 Immunostaining results.
All sections are from the CA3 region of hippocampus, stain is always 
brown and 3 mice per line for each time point were done.
3.5.6 Kainic acid (KA) injected C57BL6 wildtype mice compared with 
saline injected controls.
Figures A to K compare the response of the wildtype C57BL/6J 
background stain to KA injection for 3 hour and 24 hour time points post 
injection (Figures 3.7, 3.8, 3.9, 3.10 and 3.11). The 4 day and 7 day post 
KA injection time points showed no difference in staining or pathology in 
any of the strains.
At 3 hour post KA injection REST and REST4 remains cytoplasmic but 
both appear weaker in the KA wildtype (Figures 3.7 and 3.8). ADNP 
remained the same at this time point in both saline control and KA subjects 
and was always nuclear.
At 24 hours the ADNP staining is weaker in the KA injected mice in 
comparison to the saline injected (Figure 3.9). In addition, the REST and 
REST4 appear to be weaker in the KA mice compared with the saline 
controls (Figures 3.10 and 3.11).
Overall, no obvious pathology in the wildtype strain at the low dose of 
17mg/Kg KA injection in comparison to the saline injected controls.
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Immunostaining results.
All sections are from the CAB region of hippocampus, stain is always brown and 3 mice per strain for 
each time point were done.
Kainic acid (KA) injected C57BL6 wildtype mice compared with saline injected wildtype controls.
B.KA 3 hour anti-RestA. Saline control anti-Rest.
Dark neurons
\
20.00 um20.00 um
Figure 3.7 Wildtypes at 3 hours post injection looking at REST. (A) Shows Rest staining in saline 
control, lots of cells are stained and it is always cytoplasmic. (B) is the 3 hour time point for Rest 
staining in wild type mouse, it is much weaker expect for a few "dark neurons" (damaged or dying) 
where the staining is stronger.
Figure 3.8 Wildtypes at 3 hours post injection looking at REST4. (C) And (D) show Rest 4 staining 
which is present in some cells in control and always cytoplasmic. In the KA 3 hour time point (D) it is 
much weaker but remains cytoplasmic.
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Figure 3.9 Wiidtypes at 24 hour post injection looking atADNP. (E) and (F) show staining for 
ADNP which is nuclear in both the control (E) and KA 24 hour time point (F) but the KA (F) is much 
weaker with only one stained neuron (arrowed).
Figure 3.10 Wiidtypes at 24 hour post injection looking at REST. (G) Shows Rest staining in 
saline control, always cytoplasmic and in nearly all cells. (H) is KA 24 hour time point in wild type 
mouse, staining is much the same only weaker.
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Figure 3.11 Wiidtypes at 24 hour post injection looking at REST4. (J) Shows Rest 4 staining in 
control, cytoplasmic and in some cells. (K) shows KA 24 hour time point, staining for Rest 4 is much 
weaker.
95
3.5.7KA injected double knockouts compared with KA injected wildtype 
controls.
At the 3 hour post KA time point REST and REST4 appears similar in 
double knockout compared to the wildtype except for the complete absence 
of REST in the necrotic neurons of the double knockout (figure M).
The most interesting observation at this time point is for ADNP which 
remains nuclear in the KA wildtype but has gone cytoplasmic in the double 
knockout with the exception of one dark neuron (figure O).
At the 24 hour post KA injection the REST staining is stronger than in the 
wildtype but it is completely absent in the necrotic cells (figure Q).
For REST4 at 24 hours the staining is much stronger in the double 
knockouts than the wildtypes (figure S).
Again, the most interesting observation is the fact the ADNP is nuclear in 
the wildtype but remains cytoplasmic in the double knockout as observed 
at the 3 hour time point (figure U).
The ADNP was only found totally in the cytoplasm for the double 
knockout strain and only at time points 3 hour and 24 hour post KA 
injection.
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KA injected double knockouts compared with KA injected wildtype controls.
Z..KA WT 3 hour anti-Rest M. 3 hr KA double knockout anti-Rest
»
J
I
20.00 urn
Figure 3.12 KA control IVTs and double knockouts at 3 hours post injection looking at REST. In KA 3
hour wild type time point (L) the Rest is staining strongly only in dark neurons. In the KA double KO 3 
hour time point (M) there is still lots of staining for Rest but complete absence of staining in necrotic 
neurons (arrowed in red).
Figure 3.13 KA control WTs and double knockouts at 3 hours post injection looking at ADNP.
The KA 3 hour wildtype (N) shows ADNP staining always nuclear in some neurons. In the KA 
double KO 3 hour time point the ADNP has gone cytoplasmic (except for one dark neuron, red 
arrow). The double KO was the only strain to show this complete change in ADNP staining.
97
T
Figure 3.14 KA control WTs and double knockouts at 24 hours post injection looking at REST.
In the KA 24 hour time point for wild types (P) the Rest staining is similar to saline control (G). In 
the KA 24 hour time point double KO the Rest staining is strong in dark neurons but completely 
absent in necrotic cells (red arrows).
R. KA 24 hour anti-Rest4 | 5. 24 hour KA double KO anti-Rest4
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Figure 3.15 KA control WTs and double knockouts at 24 hour post injection looking at REST4.
In the KA 24 hour time point for wild types (R) the Rest 4 staining was much weaker than wild 
type saline control (J). In the KA 24 hour time point for the double KO the Rest 4 remained 
cytoplasmic but there was an increase in expression, more than both the saline control and wild 
type KA mice.
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U. 24 hour KA double KO anti-ADNPr. KA 24 hour anti-ADNP
Figure 3.16 KA control wildtypes and double knockouts at 24 hours post injection looking at 
ADNP. In the wild type KA 24 hour time point the ADNP is much less than saline control but 
remains nuclear. In the double KO KA 24 hour time point the ADNP has gone cytoplasmic (as with 
3 hour time point) but remains absent from necrotic cells (red arrows).
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3.5,6 KA injected Tael knockout compared with KA injected wildtype 
controls.
At 3 hour time point the KA injected Tael knockouts were similar to the 
KA injected wildtypes.
Only at 24 hours post KA injection was any difference observed in this 
strain.
At 24 hours post KA injection the REST staining in the Tael knockout was 
stronger than in the wildtypes but REST4 remained similar in both.
The most interesting observation in this strain was for the ADNP which at 
24 hours post KA injection was found not only in the nucleus but also in 
the cytoplasm. The Tael knockout at this time point was the only strain 
that had ADNP both nuclear and cytoplasmic.
The Tacrl knockout was no different to the wildtype controls for all time 
points post KA injection.
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KA injected Tael knockout compared with KA injected wildtype controls.
Figure 3.17 KA control wildtypes and Tael knockouts at 3 hours post injection looking at REST.
The wild type KA 24 hour time point (V) staining for Rest was similar to the saline control (G). The 
KA Tael KO 24 hour time point staining for Rest was more intense than both of them but remains 
cytoplasmic (W).
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Figure 3.18 KA control wildtypes and Tael KOs at 24 hours post injection looking for REST4. The
Rest 4 staining in the wild type KA 24 hour time point (X) is much weaker than in saline control (J). 
The Rest 4 staining in the Tael KO KA 24 hour time point is similar to (X) except that it is more 
intense in the dark neurons of which there are a lot (red arrows).
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Table 3.1 Summary of immunostaining in positive cells 24 hours post KA injection in CAS region of 
hippocampus.
Genotype status of
mouse line
Expression found in cytoplasm for:- Expression found in nucleus for:-
Rest Rest4 ADNP Rest Rest4 ADNP
Wildtype +++ +++ 0 0 0 (+)
Tael knockout +++ +++ + 0 0 +
Double knockout +++ +++ ++ 0 0 0
Key. The immunostaining was scored as follows for 400x field: 0 = no positive cells or staining 
reactions; (+) = very few (up to 5) positive cells or staining reactions; + = few (up to 15) positive cells 
or staining reactions; ++ = moderate numbers (15 or more) positive cells or staining reactions; +++ = 
high numbers (30 plus) positive cells or staining reactions.
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Haematoxylin and Eosin stain from 24 hour KA injected double knockout.
Figure 3.20 H&E staining of double knockout hippocampus CAS region at 24 hours post injection.
Section of CAS region of the hippocampus of a double knockout (Tael-/- * NK1-/-) at 24 hours post KA 
injection. A number of necrotic neurons can be seen shrunken with pink stain round them indicating 
neuronal damage, this amount of necrotic neurons where not found in any other H and E staining for 
any other strains or time points. Necrotic neurons typically demonstrate the gradual disintegration of 
intracellular organelles and dispersion of their remnants into the surrounding area (Ferenc et al, 
2008).
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3.6 Discussion
The data presented in this thesis indicates that the double knockout is 
distinct from the single knockouts and that the disruption of preferred 
ligand and receptor pathway has generated a unique phenotype both 
behaviourally and pharmacogenetically.
3.6.1 Tacrl KO and double knockout display anxiolytic behaviours in 
comparison to their WT controls
As previously mentioned SP is the most abundant neurokinin in the CNS 
and its preferred receptor Tacrl is highly expressed in regions involved in 
affective disorder and responses to stress and anxiety. In the light dark 
experiment, which measures anxiety, the Tacrl-/- and the double knockout 
were less anxious than the wildtype controls with statistical significance. 
The Tael-/- was less anxious than the wild type C57BL/6J control but this 
was not statistically significant. This is consistent with published data and 
is an indication of the effect the SP/Tacrl pathway has on anxiety control 
supporting the evidence for links and modulation of the serotonin (5HT) 
system (Santarelli et al, 2001) as discussed in the introduction of this thesis 
(chapter 1.6). This is reviewed by Blier, et al, 2004, were the 
electrophysiological, neurochemical and behavioural studies show an
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effect by the TACR1 antagonists that is similar to the effect afforded by 
various antidepressant drugs. On a behavioural level, the SP/TACR1 
pathway controls the “fight or flight” response which is emotionally 
mediated by the fear response. It therefore is logical that there is an 
interconnected neuronal network between SP, TACR1 and the release of 
5HT and epinephrine (adrenaline) Blier et al, 2004.
This is further substantiated by the fact that SP is released in the rodent 
brain in areas associated with emotional behaviour such as the 
hippocampus and the previously mentioned amygdala, hypothalamus and 
PAG. In addition, SP is increased in these areas in the rodent brain in 
response to novelty, restraint and social isolation which are all associated 
with changes in serotonin levels and regulation (Rodgers et al, 2004).
In the case of anxiety SP may have been evolutionally selected for its role 
in increasing anxiety levels and ensuring behaviour that is not too bold 
which would inadvertently increase the risk of a prey animal (rodents) 
being hunted to extinction. Interestingly, some parasites actually alter the 
behaviour of the hosts they infect to ensure that their anxiety levels are 
suppressed and they become bolder in their exploratory behaviour which 
ensures the parasite ends up in the definitive host for its life cycle. For 
example, the parasite Toxoplasma gondii manipulates the behaviour of its 
intermediate host, rats, to ensure it reaches its feline definitive host. This
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“manipulation mechanism” could have evolved in parasites to combat the 
evolving cautious behaviour that we interpret as anxiety (Berdoy et al, 
2000). In addition, even through humans are an accidental host for 
Toxoplasma gondii and represent a dead end host the parasite is still able to 
alter the behaviour and brain functions of patients evidenced by reports of 
altered personality, deafness and lowered IQ levels in infected individuals 
(Sever et al, 1987). This indicates a common evolutionary pathway that is 
available for manipulation by this parasite that is conserved from rodents to 
man. Whilst 5HT antagonists can emulate the same response it is 
interesting to note that TACR1 antagonists and Tacl/Tacrl mouse 
knockout models can also illicit the same behavioural response indicating a 
common regulatory pathway (Kramer et al, 2007).
Although the Tael KO had lower anxiety levels than the wildtype control 
it was not statistically significant. Previous studies, however, have found 
the Tael KO used in this thesis to have significantly lower anxiety levels in 
comparison to their wild type controls (Bilkei-Gorzo et al, 2002). 
Increasing the numbers of mice used may result in statistical significance. 
Further testing with a variety of behavioural tests for anxiety would allow a 
more confident conclusion.
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3.6.2 The double knockout demonstrates a phenotype in response to 
stress induced depression that is unique in comparison to its single KO 
parental strains
The Porsolt forced swim test is considered a model for measuring stress 
induced depression in rodents. In this test the double knockout was 
significantly different to the single knockouts. The single knockouts Tacrl 
and Tael showed a resistance to stress induced depression compared to 
their wild type controls, this result is consistent with the published 
literature (Bilkei-Gorzo et al, 2002). The double knockout was predicted to 
show a resistance to stress induced depression and was speculated to be 
even more resistant than its single knockout contributors but surprisingly it 
showed a susceptibility to this kind of depressive event with statistical 
significance compared to the wild type control. Whilst this was 
unexpected it does fit with the theory of redundancy discussed earlier on in 
the introduction (chapter 1.5). The single knockouts have part of a 
preferred ligand/receptor pathway intact, the receptor Tacrl is present in 
the Tael-/- and the ligand SP is present in the Tacrl-/-. Thus, in the 
absence of SP it may be that another neuropeptide can bind and activate the 
Tacrl, e.g. NKA or NKB. Likewise, in the absence of Tacrl it may be that 
SP elicits its function via another G protein coupled receptor, e.g. Tacr2 or 
Tacr3. However, the absence of both ligand and receptor pathway means 
that compensatory mechanisms are unable to play a part and a more
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detrimental phenotype emerges as is the case with the double knockout and 
its susceptibility to stress induced depression.
Until recently it was thought that other neuropeptides could bind and illicit 
a biological response via the Tacrl but it was generally accepted that SP by 
far demonstrated the greatest affinity for the receptor. However, it would 
appear that a recently discovered neuropeptide called hemokinin 1 (HK1) 
which is expressed from the Tac4 gene shows remarkable similarity to SP. 
It is 11 amino acids long and shares a 55% homology with SP and, most 
importantly, demonstrates the same affinity for the Tacrl as SP. 
Expression of HK-1 was initially demonstrated in mouse bone marrow and 
thymus with additional evidence that in bone marrow, HK-1 expression 
was largely restricted to B cells (Zhang et al., 2000). Further data, 
however, have illustrated moderate to strong expression in the brain, 
spleen, stomach, skin, lactating breast, and uterus (Kurtz et al, 2002; Patak 
et al, 2003).
It was also discovered that HK1 shares the same cell origin and is co­
expressed along with SP at numerous sites and both are involved in the 
same immune regulatory functions (Metwali et al 2011). In humans the 
TAC4 gene codes for a peptide with homology to the murine HK1 and in 
addition a truncated form of the peptide (Kurtz et al 2002). What this 
suggests is that HK1 and SP could have evolved together in mammalian 
systems to control and regulate vital immune responses and also
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behavioural responses. Interestingly, HK1 exerts anti-anxiety and enhanced 
stress coping actions which contrasts the Tael coded neuropeptides in 
behavioural responses (unpublished data from Z. Helyes, University of 
Pecs and A. Berger, University of Toronto). Whilst the data in this thesis 
supports these findings with regards anxiety related behaviours it is not 
substantiated in the stress induced depression model. This may be an 
indication that HK1 plays less of a role in this pathway than in the anxiety 
related response pathway where it would appear that the absence of SP and 
its effects via the Tacrl allows HK1 to exert its anxiolytic properties 
unchallenged possibly via the proposed HK1 receptor in the Tacrl 
knockout. At the time of writing this thesis a new mouse model that has its 
Tac4 gene disrupted resulting in mice that are null for HK1 was being 
utilised in experiments in both Toronto and Pecs to investigate these 
hypothesises further.
3.6.3 The double knockout demonstrates a lower threshold for 
chemically induced seizures that is in contrast to the single KOs
Besides its role in the mood disorders, SP has been associated with one of 
the most common neurological disorders, epilepsy. However, the literature 
remains conflicting with some evidence showing SP as a powerful pro- 
convulsant and others finding evidence to suggest it has a protective role as
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an anticonvulsant via its preferred receptor Tacrl (Toth et al, 2007; 
Maubach et al, 1998; Liu et al, 1999). More recently association between 
serotonin and the development and aetiology of epilepsy has been made 
(Stefulj et al, 2010; Bagdy et al, 2006; and Chugani et al, 2005). Generally 
speaking, agents that elevate 5HT levels tend to inhibit epileptic seizures 
and a depletion of brain 5HT levels confers a susceptibility to chemical and 
electrical evoked seizures (Bagdy et al, 2006). In addition, mouse 
knockouts for the 5HTia or 5HT2C receptors display a lower seizure 
threshold and increased seizure activity implicating the signalling 
mechanism by which varying levels of 5HT contributes to seizure activity 
and susceptibility (Bagdy et al, 2006).
This is further reinforced by the receptors distribution in the brain with 
5HTia being the major postsynaptic receptor in areas associated with 
seizure activity such as the hippocampal, cortical and hypothalamic regions 
(Sanryai et al, 2000; Brennan et al, 1997; Tecott et al, 1995). Tacrl 
knockouts have documented lowered anxiety levels and resistance to stress 
induced depression which is supported by the data in this thesis. This is in 
conjunction with an increased firing rate of the 5HT neurons in these mice 
(Gobbi et al, 2005). The increased firing of the 5HT neurons was also 
detected in wildtype mice that were acutely treated with the Tacrl 
antagonist, RP67580 (Santarelli et al, 2001). The data presented in this 
thesis documents the seizure susceptibility of the double knockout that
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could be due to the absence of a SP/Tacrl pathway of regulatory control of 
5HT levels.
Moreover, epilepsy is associated with a high incidence of depression 
(Lothe A et al, 2008; Bagdy et al, 2006)). Conferences that were run at 
Aintree hospital to encourage an interdisciplinary overlap between the 
clinical consultants treating human epilepsy patients and the scientific 
researchers studying the molecular and biochemical causes of epilepsy 
suggest a high incidence of depression in their patients. Particularly 
relevant to this thesis is the fact that they also associated an increased risk 
of seizure with women’s menstruation cycle and this will be discussed 
further in this chapter.
We therefore tested the hypothesis that the double knockout, whose genetic 
and transcriptional plasticity seems to pre-dispose it to stress induced 
depression, would have a greater susceptibility to chemically induced 
epileptic seizures. Although the results are very preliminary, the double 
knockout (that showed a statistically significant predisposition to stress 
induced depression in the Porsolt forced swim test) was also the strain that 
had the most severe chemically induce seizures in the male mice. As 
mentioned previously, these results were surprising as it was originally 
hypothesised that the double knockout may have a phenotype similar to the 
two single knockouts, Tael and Tacrl respectively. In fact this study found
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that knocking out both ligand (SP) and preferred receptor (Tacrl) 
simultaneously altered the phenotype of the animal in a way that was 
unique from the single knockouts and gave totally different responses in 
experimental studies both behaviourally and pharmacologically. As 
mentioned the single knockouts maybe utilizing alternative ligand and 
receptors which, in the absence of SP and Tacrl, compensate to regulate 
and facilitate the system they are involved in even if it is not to the same 
efficiency (lienee an alteration in phenotype documented in the single 
knockouts). This would suggest that a level of redundancy does exist in the 
single knockouts and the interaction of compensatory tachykinins and 
receptors are playing a role in the observed phenotypes.
One possible suggestion for the unexpected severity of the seizures seen in 
the double knockouts (even at the low dose of Kainic Acid, 17mg/Kg) is 
that the NK3 receptor and one of its ligands NKB may be playing more of 
a role in the system. NKB is a documented proconvulsant (Gillies et al, 
2009). Another possibility, as mentioned earlier, is that serotonin is playing 
a role and the double knockout is having more of detrimental effect on the 
regulation of this neurotransmitter. As mentioned previously the 
neurotransmitter serotonin, and its main regulator 5HTT, are historically 
well documented to be pivotal in the control of mood and behavioural 
disorders and a regulatory link between 5HT, SP and the receptor Tacrl is 
documented (Valentino & Commons, 2005; Santarelli et al, 2001). It is
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possible that the absence of either SP or the Tacrl receptor “dampens 
down” the endogenous systematic response to stress and the regulation of 
5HT levels which is the organisms natural defensive mechanism to ensure 
survival; too prone to stress induced depression and the animal would lack 
the motivations to mate, seek food and shelter and fight for territory 
effectively resulting in its extinction. If, however, it was too resistant to 
stress induced depression then this would result in risky behaviour in the 
pursuit of its motivations and with the mouse being a heavily preyed upon 
animal this would also ultimately result in its extinction. This conflict of 
pursuit of motivations verses the survival instinct may have been 
responsible for the emergence of a seemingly conflicting regulatory system 
with regards HK1 and SP and their affinity for the Tacrl.
As previously suggested, it may be that the removal of the preferred 
pathway that is critical to the regulation of affective behaviour and 
neurochemical responses to stress has led to the double knockout showing 
a predisposition to stress induced depression. The removal of either SP or 
Tacrl receptor merely challenges the system and the regulation of 5HT 
levels, resulting in a still functioning but impaired response to various 
stimuli, whereas the removal of the entire preferred pathway leads to a 
dysregulation of 5HT levels that is much more pronounced, in particular 
with regards the Kainic acid study. This would need further testing and 
measurement of 5HT neuronal firing in these models to substantiate.
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3.6.4 The modulation of 5HT levels via the SP/Tacrl pathway and its 
implications in epilepsy
As mentioned in the introduction of this thesis Santarelli et al (2001) found 
that SP is increased in the cerebral spinal fluid (CSF) of depressed patients. 
Also, as mentioned, disruption (Tacrl knockouts) and drug blockage 
(MK869, NKP608) of the Tacrl receptor reduces anxiety and stress in 
conjunction with an increased firing rate of serotonin neurons in the dorsal 
raphe nucleus of mice (Gobbi et al, 2005; Bilier et al, 2004). This fits with 
the theory that SP and Tacrl play a role in regulating 5HT levels and 
blocking its effect removes the regulatory mechanism and may lead to 
aberrant 5HT levels. Depletion of brain 5HT lowers the threshold to 
chemical induced seizures as well as electrically evoked ones (Bagdy et al, 
2006). If SP was acting via Tacrl receptors as a damping mechanism then 
removing it (Tael knockouts) or blocking its effects (Tacrl knockouts or 
antagonists) would result in an elevation of 5HT levels which would result 
in a phenotype of seizure resistance.
This is indeed what has been documented in some papers as well as a 
detectable increase in 5HT levels (Bagdy et al, 2006; Santarelli et al, 
2001). Tacrl antagonists also made it as far as human clinical trials as they 
had antidepressant effects on patients with moderate to severe depression
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generally via raising 5HT levels. With this in mind then during a seizure 
event when the firing of excitatory neurotransmitters are increasing it could 
be suggested that SP may be increasing not as a pro-convulsant but in a 
regulatory and protective role trying to return control to the system. Its 
increase and apparent effects as a pro-convulsant may be masking other 
neuropeptides or neurotransmitters that are playing more of a role in the 
epileptic episode. This runs contrary to the vast majority of published 
literature which documents SP as a pro-convulsant often painting it as a 
tachykinin that needs to be controlled in order to limit the damaging effects 
of seizures (Liu et al, 1999), but could its increase in levels during seizure 
actually be a damage limitation attempt by a system that in evolutionary 
terms has developed as a protective mechanism (Maubach et al, 1998).
This would fit in with the many other roles SP has as a protective 
neuropeptide. Unfortunately an unprecedented series of events is initiated 
during seizure including an increase in excitatory glutamate release and 
levels of NKB (a hypothesised pro-convulsant) and it may take time for 
control to return, if during this time the levels of SP have been raised to 
such a level as to over compensate then this would also present problems. 
If 5HT levels dropped too much then the reduction of brain 5HT 
concentrations would lead to a susceptibility to future seizures (Chugani et 
al, 2005), and this is indeed the case in Status Epilepticus. Interestingly, a 
recently published article in epilepsy research alluded to the same
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conclusion and found an association with the less transcriptionally efficient 
combined genotypes of the 5HTTLPR and 5HTTVNTR allele variants and 
temporal lobe epilepsy (Schenkel et al, 2011).
The results of the HE and histochemical staining showed that only in the 
double knockout strain at time point 24 hours post KA injection was there 
any pathology found in the neurons of the CAS region of the hippocampus 
(figure 3.20). In all the other strains and time points (including 3 hour, 4 
days and 7days for the double knockout) the pathology in the KA injected 
subjects was the same as the saline injected controls. This is consistent 
with the findings of the behavioural testing following KA injection 
whereby the double knockout showed a surprising sensitivity to the KA 
and had full seizures even at the low 17mg/Kg dose and also with 
published literature which shows that 24 hours is the time period were the 
majority of observed pathology occurs, hi fact, the same neuronal damage 
has been reported in wildtype C57BL/6J mice but this was using a 
35mg/Kg dose when the mice also displayed full seizures (Benkovic et al, 
2006). However, during the dose range study the 35mg/Kg proved to be 
lethal in our hands. A lower dose was used in the Benkovic paper for aged 
C57BL/6J mice as it is reported that they have an increased sensitivity to 
KA and for mice in the group age 20 months plus only 20mg/Kg KA was 
injected. This is a very interesting observation which is of particular
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relevance with regards the sex specific differences we observed in this 
thesis and this will be discussed further on in this section.
3.6.5 The transcription factors REST and REST4
Since previous work in our group had proposed an inteiplay between 
REST (repressor element-1 silencing transcription factor, also referred to 
as neuron restriction silencing factor, NRSF), REST4 (a truncated valiant 
of REST) and expression of SP by modulation of the Tael gene we used 
immunohistochemistry to investigate the expression and presence of these 
transcription factors in the CA3 region of the hippocampus in control and 
KA injected mice (Spencer et al, 2006). The only time points that showed a 
different staining or pathology from the saline controls and wildtype KA 
injected controls where at 3 hours and 24 hours. Although preliminary, this 
is consistent with published literature and the findings in our lab with 
regards the critical time point for molecular changes and neurological 
pathology.
Spencer et al (2006) found an up regulation of REST4 at 3 hour through to 
24 hour post KA injection in rats in the CA1 area of the hippocampus. This 
publication also documents a more modest increase in REST and both 
REST and REST4 exhibit this increase in expression only transiently up to
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and including 24 hour post KA injection. These findings are partially 
reflected in the immunohistochemistry results in this thesis using mice and 
observing the CA3 region of the hippocampus. Staining for REST was 
stronger in the Tael and double knockouts at time point 24 hour post KA 
injection consistent with the modest up regulation found by Spencer et al. 
REST4 staining was only found to be much stronger in the double 
knockout stmin at 24 hour post KA injection. Since the Spencer study used 
rats and all rats received a dose of KA that induced full seizure the results 
of this thesis contribute towards validating the findings in the rat model. 
The double knockout was the only strain to exhibit full seizure at the low 
dose of 17mg/Kg and it was in this strain at time point 24 hours that 
stronger staining for both REST and REST4 were observed alongside 
neuronal damage in the CA3 region. Although the Tael knockout also 
exhibited a stronger staining for REST at 24 hours without any seizures or 
pathology this would be expected if REST was a modulator of SP levels as 
there would be no elevation of SP in this null model. However, the 
speculation that the removal of the complete SP and Tacrl pathway 
negates the redundancy effect and any compensatory mechanisms still 
applies and the double knockouts susceptibility to chemically induced 
seizures may be a result of another pathway playing a role, such as NKB 
and Tacr3 which accelerates the molecular dysregulation of the 
hippocampus leading to full seizures and ultimately neuronal damage. 
Likewise, this hypothesis can be reversed and it may be the loss of both
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parts of a protective mechanism is what contributes to the neuronal damage 
and full seizures even at low doses of KA that are observed in the double 
knockout.
3,6.6 The double knockout andADNP
ADNP (activity dependent neuroprotective protein) has been postulated to 
have neuroprotective properties due to it containing an eight amino-acid 
sequence (which has been termed NAP) which has been shown to have 
strong neuroprotective effects in a variety of models (Gennet et al, 2008; 
Steingart and Gozes, 2006). Gennet et al found that different localisation of 
ADNP correlates with different cell states and postulated that, similar to 
the action of some transcription factors such as NFkB, the inactive fonn is 
sequestered in the cytoplasm and only on translocation to the nucleus is it 
activated.
Of particular interest in the results of this thesis is the observed localisation 
of ADNP in the Tael and double knockout models at 24 hours post KA 
injection. Although preliminary, the double knockout line was the only one 
to succumb to a full seizure and additionally shows a differential 
expression of ADNP which is exclusively in cytoplasm in the field of study 
in comparison to the other lines which demonstrate expression in the
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nucleus. Intriguingly, the Tael knockouts had an observed dual expression 
of ADNP in both the cytoplasm and the nucleus. Since ADNP is a VIP 
regulated protein and an interaction of SP and ADNP regulation is 
documented (Thippeswamy et al, 2007) it could be that disruption of SP in 
the Tael knockouts is altering the expression of ADNP upon insult and 
resulting in additional expression in the cytoplasm as well as nucleus. 
However, with complete disruption of the SP/Tacrl pathway in the double 
knockouts it may be a more pronounced altered expression of ADNP is 
being observed exclusively in the cytoplasm, this would support the 
hypothesis of redundancy in the single knockouts with observed regulatory 
disruption of associated proteins such as ADNP being far more 
demonstrative in the double knockout line.
However, contrastingly, if one was to presume that ADNP has a role in 
neuronal protection and adaptive pathways that are activated on insult then 
the altered expression and translocation of ADNP to the cytoplasm in the 
double knockout genotype at 24 hours may be an indication of its 
neuroprotective actions given the double knockouts susceptibility to 
chemically induced seizure.
The interesting observation of ADNP in both the cytoplasm and nucleus of 
the Tael knockout at 24 hours post KA injection would suggest a “partial 
activation” of ADNP protective properties due to the absence of SP but
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how this would correlate with the documented seizure resistance observed
in this strain remains unclear'.
Some proteins are inactive in the nucleus and are only activated on 
translocation to the cytoplasm. Therefore, if this was the case for the action 
of ADNP then it could indeed be postulated that the double knockouts 
susceptibility to KA induced seizures is the reason that this strain was the 
only one whose ADNP protective properties were activated explaining the 
total translocation of all ADNP to the cytoplasm of the neurons. The 
presence of ADNP in the nucleus of “dark neurons”, which are known to 
occur as a consequence of even very subtle traumatisation of neurons 
(Cammermeyer, 1961), may then be observed as the inability of those 
neurons to adapt to the insult which ultimately is their demise. It would be 
interesting to observe ADNP localisation in all the lines at a line dependant 
dose that would induce full seizure in those animals. Whilst the observed 
differences in ADNP localisation in this thesis is supportive of ADNPs 
possible protective action during neuronal insult more research is needed to 
clarify its role in pathological conditions of the CNS such as epilepsy.
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3.6.7 The sexual dimorphism demonstrated in response to KA induced 
seizure activity
The purpose of the dose range study was to evaluate a level of KA that 
would not induce a full seizure in wildtype C57BL/6J mice in order to 
study the subtle behavioural changes and the stages of seizure that precede 
a full seizure. The peer reviewed literature documents cases were the dose 
of KA always invokes a full seizure. The problem with this is that neuronal 
damage will inevitably ensue from such a large dose of neurotoxin leading 
to the inevitable dysregulation of numerous neuropeptides, 
neurotransmitters, transcription factors, proteins and inflammatory factors 
which could mask die actual pathways involved in epileptic seizures.
Experimental design recommendations often quote grouping mixed sexes 
together in batches as long as sex and age is balanced among the groups 
especially with regards the control group. In the dose range study 3 males 
and 3 females, all C57BL/6J and age matched, were grouped together for 
each of the three doses (15mg, 25mg and 35mg/Kg). Immediately it 
became obvious that the females showed an increased sensitivity to the 
effects of KA. This can be clearly seen in figure 3.5 were the females for 
all the strains exceeded the seizure severity compared to their male 
counterparts with statistical significance. In figure 3.3, the dose range male 
vs. female results, the clear difference in female seizure severity scoring
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can be seen. However, this difference disappears at 25mg/Kg and the 
males show a slightly higher seizure severity score.
This highlights the point made earlier about large doses of neurotoxin such 
as KA masking the subtle differences in seizure activity and propagation as 
the threshold for full seizure is exceeded for both of the sexes. With the 
males the double knockout showed a statistically significant sensitivity to 
KA induced seizures and the Tael and Tacrl knockouts showed a slightly 
lower seizure score compared to the wildtypes which is consistent with the 
published literature although this was not statistically significant in our 
hands. This was not seen in the females, however, all of the strains 
exhibited an unexpected full seizure even at the low dose of 17mg/Kg and 
it could be that the seizure threshold for the female sex has been exceeded 
and a lower dose for females may show a difference between the lines.
This thesis demonstrates why a lot of researchers tend to study one sex in 
their experiments. The majority of pharmacologists prefer to study males 
not only because they have a higher metabolic rate which favours efficient 
drag metabolism but also because females have variations in hormone 
levels during their oestrous cycle. This is of particular concern in the 
mouse as female’s cycle every five days in this species thus presenting a 
problem with variables introduced from individual to individual. For 
translational purposes any treatments or drags would eventually be used in
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both male and female humans so it is important to remember that any 
analysis should take account of possible differences in response between 
the sexes.
Females differ from males at the cellular, molecular and whole organism 
level. The obvious difference is the presence of the Y chromosome in 
males and the fact that females have two X chromosomes. Only one X 
chromosome is required which is why males manage fine with XY, in fact 
if both X chromosomes where to express in the female the result would be 
very detrimental which is why there is transcriptional silencing of one X 
chromosome in females known as X-chromosome inactivation. The 
silencing, achieved through methylation and the production of a ball of 
inert DNA known as the Barr body, is established in development and is 
stable with the same X chromosome remaining inactivated in all 
subsequent cell generations. However, this inactivation is random and 
results in the female being a mosaic of cells in which either the maternally 
inherited or paternally inherited X chromosome is silenced thus adding 
another layer of variability to the research model. This, however, is less of 
a problem in a properly maintain inbred mouse line due to the homologous 
genetics but it would have consequences in an outbred colony.
A recent analysis of gene expression in mice demonstrated substantially 
sexual dimorphic expression in the brain, liver and adipose tissue and
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whilst both sexes make the same steroid hormones they are found, of 
course, in different quantities (Yang et al, 2006). All of this can contribute 
to why such a pronounced difference was observed in seizure severity 
between the sexes after KA injection. More specifically, it may actually be 
the sexual differences in the SP Tacrl pathway that is causing the 
conhasting sexual effects we observed. A recent study in humans found a 
sexual dimorphic difference in the SP/Tacrl binding potential in males and 
females. The females consistently demonstrated a lower binding potential 
for SP with Tacrl in numerous areas of the brain including the 
hippocampus. The data demonstrated that on average females have a lower 
brain Tacrl binding potential (BP) with the most marked area being in the 
putamen where females had a 19% lower Tacrl BP compared to males 
(Nyman et al, 2006). The putamen is involved in motor control and 
learning and modulates neurotransmitters and neuropeptides including 
serotonin, glutamate and SP. Interestingly, the same study found age 
related changes in the SP/Tacrl system with a decrease in the Tacrl 
binding potential strongly associated with increasing age.
This could be a possible explanation as to why aged male mice show an 
increase in sensitivity to KA induced seizures that is also replicated in 
females. By contrast, serotonin (5HT1A) and GABA receptors do not 
appear to change with age but it is known that there are alterations in 
glutamate and monoamine systems with increasing age mid the recent
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observations of an age related decrease in Tacrl binding potential and the 
consequences this disruption would have on die systems regulated by this 
pathway may offer an explanation. In addition, the menstrual cycle is 
known to disrupt Tacrl binding and epileptic women often suffer from a 
seizure exacerbation aligned with their menstrual cycle. This phenomenon 
is termed catamenial epilepsy and is characterized by recurrent seizures, 
however, it is known that oestrogen can influence neuronal excitability but 
the disruption of the SP and Tacrl binding potential may be a contributing 
factor also (Vendruscolo et cil^ 2003).
Of particular interest to this thesis are the recent publications suggesting a 
direct regulatory effect of oestrogen on levels of neuropeptides (Ranee et 
al, 2010; Sarajari and Oblinger, 2010), in addition, oestrogen has been 
shown to have a negative effect on SP expression. For example, 
oestrogen treatment has been shown to decrease SP levels in the anterior 
pituitary (Brown et al. 1990; O'Halloran et al. 1990) and this may be due 
to Tael downstream events in non-coding regulatory regions. It is 
possible that this regulatory mechanism offers an explanation as to why 
the females show a susceptibility to chemically induced seizures and this 
would require more investigation, however, it may also be plausible that 
the knockout models used in this thesis and the experiments employed 
have merely demonstrated an evolved sexually dimorphic function of a 
regulatory system. As mentioned previously, the SP/TacrT pathway is
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involved in anxiety, fight or flight response and pain perception. Males of 
most species (including mice) are highly motivated to seek territory and 
possible mating opportunities with females. The male’s investment in 
gamete production is low and infinite, billions of sperm are produced 
daily, the female’s investment in her gametes on the other hand is high 
and finite and in many species it is the female sex that provides post natal 
nurturing. It is in the male’s interest to take risks and potentially expose 
themselves to situations that result in pain (confrontational competitions) 
because the potential rewards are so great (access to mating opportunity) 
in comparison to the investment in gamete production. The females 
contrastingly have a great deal to lose if they have risky behaviours as 
any injuries or confrontations could result in the loss of an entire litter 
and detrimentally impact any future mating opportunities. It could be that 
the SP/Tacrl pathway plays a role in the management of this investment 
versus reward motivations and behaviours and thus the sexes have a 
differential response in regulating levels of expression of specific 
tachykinins and their preferred receptors but this would, of course, 
require a great deal more investigation to substantiate.
An interesting further investigation would be to lower the dose of KA to 
see if there is a strain dependant difference in females as demonstrated by 
the males. In addition, all sections in the immunohistochemistry were taken 
from male subjects it would be interesting to examine female CAS regions
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post KA dosage if a low enough dose could be calculated. This thesis 
hypothesises that there would be neuronal damage in all the females for all 
die strains since they all reached full seizure if the 17mg/Kg dose was 
repeated. If a lower dose was determined then a repeat of the above study 
using females may well be worthwhile but it is recommended that vagina 
smears are conducted to ensure all subjects are at the same stage of the 
oestrous cycle to eliminate the variability that this contributes to the data.
One of the aims of tiiis thesis was to investigate and address the limitations 
of the use of hansgenic and knockout mouse models and demonstrate some 
experimental designs that could overcome some of these limitations. For 
example, the generation of the double knockout mouse model in chapter 
three demonstrated how some of the issues of redundancy in knockout 
models can be circumnavigated with combination knockouts that can be 
extremely useful in research. The double knockout in this thesis, in 
particular, proved to be a useful and viable model in related disciplines 
involving tachykinin research.
The cross breeding of lines is not a new or novel concept; it has been 
shown to be a particularly valuable strategy when dealing with immuno­
compromised models. For example, the toll like receptors (TLRs) are a 
class of proteins involved in the immune system response. They are single 
membrane bound receptors capable of recognising molecules derived from
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pathogenic microbes. Whilst the single knockout models revealed their 
specificity for recognising certain endotoxins, for example TLR4s 
recognition of LPS from E.coli, the combination of the available knockout 
models contributed knowledge to their functional activity when they form 
heterodimers. TLR2 forms a heterodimer with TLR1 or TLR6 with each 
dimer having different ligand specificity. These double knockout models 
have proved so useful that Jax labs now supply them to the research 
community in different combinations. The same is true for the interleukin 
receptors (IL) which form part of a “super family” of immune receptors 
along with the TLRs.
3,6.8 Data supports the redundancy hypothesis
The data presented in this thesis supports the hypothesis that the single 
knockout lines of Tael and Tacrl demonshate a level of redundancy due to 
the compensatory interactions of related tachykinins and receptors playing 
a role in the absence of SP and Tacrl respectively. The double knockout 
produced as pail of this thesis was used to demonstmte the redundancy 
phenomenon in the single knockouts in a publication by Quinn et al, 2010. 
Previously, Stewart et al, demonstrated in a transgenic mouse model that 
co-expressed the human TAC1 gene with the Lac Z marker gene 
(MacKenzie et al, 2000) that non neuronal Tael expression early after 
infection may have clinical implications for the progression of lung disease 
apart from its well characterised later role in the inflammatory response. In
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addition to this the single knockout mouse models of Tael null and Tacrl 
null have been used to assess the tachykinins role in murine 
gammaherpesvirus 68 (MHV-68) infection (Payne et al, 2001).
Since the redundancy effect is a debated area which has been doemnented 
in this thesis an opportunity existed to address the possible redundancy 
effects of Hie single knockouts with regards a role for the tachykinins in 
respiratory viral infection. This was of particular relevance given the recent 
publications of a newly found tachykinin, hemokinin 1 (HK1) that co­
localises with SP in immunoregulatory function, is expressed with SP at 
sites of chronic inflammation (Metwali et al, 2004) and also demonstrates 
the same affinity that SP has for the Tacrl (Kurtz et al, 2002). In the 2010 
publication, J.P. Quinn et al, confirmed previous results that showed a 
deletion of the Tael gene leads to an increased susceptibility to MHV-68 
infection. In addition, it was demonstrated that the absence of the Tacrl 
also showed the same results with regards increased susceptibility to 
MHV-68 infection.
However, as with the data presented in chapter three of this thesis, the 
absence of both Tael and Tacrl in the double knockout model 
demonstrated a unique and opposite effect to the single knockouts in that it 
showed an increased resistance to MHV-68 infection (Quinn et al, 2010). 
Consistent with the findings and conclusions of this thesis in chapter three,
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Quinn et al, 2010, hypothesises that the single knockouts have 
compensatory ligands and receptors that come into play in the absence of 
the preferred ones in question. Thus, as discussed in this thesis, the absence 
of either ligand or receptor challenges the regulatory control mechanism 
but in the absence of a larger preferred pathway these compensatory 
mechanisms cannot play a role. Quinn et al, suggests that the observed 
resistance demonstrated by the double knockout model may be due to a 
lack of inhibitory signalling on components of the host response mediated 
by the SP/Tacrl pathway. Clearly, this publication indicates, as does the 
data in this thesis, the unique phenotype of the double knockout in 
comparison with its single knockout contributors and how it can help 
address the problems associated with redundancy in the single knockout 
models.
3.6.9 One model, two lines and differences due to hypothesised flanking 
gene effect
As discussed in the introduction of this thesis the flanking gene sequence 
of DNA around the gene of interest in knockout models should always be 
taken into account as it can have consequences for the mouse model in 
question. In conclusion for this thesis is an example of this involving the 
mouse lines used in this thesis and the hypothesis that the differences 
documented are due to differential flanking gene effects.
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In March 2011 the data on the double knockout from chapter three of this 
thesis with regards the Porsolt forced swim test, light dark box and Kainic 
acid induction was presented in a poster for the winter neuropeptides 
conference. Another poster showcased at the conference also showed 
behavioural data on the Porsolt forced swim using Tael null mice but their 
data showed an opposite effect the data in this thesis. Whereas the thesis 
data on the Tael null strain showed a resistance to stress induced 
depression the data presented by Borbely et al> showed no difference in the 
Tael null in comparison with the wildtype controls in the Porsolt forced 
swim test. Both Tael nulls were documented as a C57BL/6J background 
and the wildtypes used were the same (C57BL/6J). Further investigation 
revealed that the Tael null used by Borbely et al, originated from Toronto 
and they were the “Basbum” Tael nulls detailed in chapter one (1.5) of this 
thesis. The Tael nulls used in this thesis for the Porsolt forced swim test 
were the “Zimmer” Tael nulls (1.5.2).
However, the Basbum Tael nulls (B6.Cg~TacltmlBbmIT) had been 
backcrossed for 10 generations onto a C57BL/6J background which is 
accepted in peer reviewed journals as C57BL/6J in background. The 
Zimmer (B6.Cg-7ac7 /m7nm,,l/j) mice had also been backcrossed for 10 
consecutive backcrosses onto C57BL/6J. In theory, they should be the 
same genetically stable null models. Interestingly, E. Borbely, who
132
presented the poster, worked in the Z. Helyes group in Pecs Hungary and 
they also had the Zimmer Tael nulls used in this thesis. On her return to 
Pecs E. Borbely repeated the forced swim test using the Basbum Tael 
nulls, the Zimmer Tael nulls and a wildtype control. The results were 
consistent with data presented in both of the posters. The Basbum Tael 
nulls showed no statistical difference to stress induced depression when 
compared to wildtypes in the Porsolt forced swim test. The Zimmer Tael 
nulls, however, showed a resistance to stress induced depression with 
statistical significance when compared with wildtype controls using the 
student t-test (personal communication Z. Helyes and J. Quinn). This 
demonstrates very different results from two knockout strains of mice that 
would be considered the same in the peer reviewed literature.
It is hypothesised that the differences demonstrated between the two Tael 
null models are due to the problem of the flanking genes effect (see chapter 
one, 1.5,1). In other words the two Tael null strains are congenic and 
retain the origin flanking sequences from the strains used in their 
generation (see chapter one, 1.4). As discussed previously, regulatory 
regions have been found up to several mega bases away from the gene they 
affect (Dickmeis and Muller, 2005) and regulatory effects could be 
different in the two Tael null models producing the different behavioural 
documented above. The MGI website (mouse genome infonnatics; 
http://www.informatics.jax.org/genes.shtmI) documents the presence of
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pseudogenes either side of the Tael gene in the C57BL/6J mouse genome 
(GM8686 and GM8676) as well as the presence of various SNPs (single 
nucleotide polymorphisms) that are specific to the C57BL/6J strain.
Pseudogenes are sequences that are generally non-transcribed and not 
translated but have an increased homology to identified genes. They are 
thought to be the dysfunctional relatives of their adjacent genes and often 
have gene like features such as promoter sequences and CpG islands, never 
the less they are considered inert of biological activity. However, recent 
publications in Nature document that some siRNAs (small interfering 
RNAs) are derived from pseudogenes (Tam et al, 2008). In addition, recent 
Nature publication documents the regulation of genes by their 
neighbouring pseudogenes (Poliseno et al, 2010). This could potentially, 
therefore, be an area of genetic variability between the two lines of Tael 
knockouts that may have consequential effects.
With regards the SNPs, any present would be specific to the BL6 strain of 
mice and the 129 ES cells used to generate the Zimmer and Basbaum Tael 
null models and therefore both could be different and have their own SNPs 
that differ from the BL6 ones. This confers additional variation that is 
unlikely to be changed during the backcrossing of these strains. However, 
since these SNPs occur' in regions of DNA in between genes they are not 
thought to have any functional activity but they are useful for identifying
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strain differences and this may be one method of answering the question of 
how different the flanking sequences in these two Tael null strains of mice 
really are.
However, there is another possible explanation as to why the two models 
are different and that is the targeting vector positioning. In the Zimmer 
model the targeting vector disrupted the Tael gene by replacing parts of 
exons 2 and 3. In the Basbaum model the targeting vector disrupted the 
Tael gene by replacing coding exon 3. The difference in positional 
disruption in the two models may have caused differences in the splice 
variants. Although the proteins SP and NKA were both doemnented as 
deleted in both models, other proteins or splice variants could be truncated 
resulting in a peptide that is detected but its functional effects could be 
disrupted. This may also account for the demonstmted differences.
In summary it is suggested that the single knockouts have alternative 
ligands and receptors that in the absence of SP and Tacrl compensate and 
still regulate and facilitate the system they are involved in even if not to the 
same efficiency (redundancy effects), however, in the case of the double 
knockout when a pathway involving a known high affinity receptor and 
ligand is simultaneously absent then it may be that another related 
receptor/ligand mechanism comes into play which may help to explain 
why the double knockout is so different.
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